Frederik Nevens

Frederik Nevens's AcademicInfluence.com Rankings

Frederik Nevens

Computer Science

#5871

World Rank

#6195

Historical Rank

Machine Learning

#1720

World Rank

#1743

Historical Rank

Artificial Intelligence

#1961

World Rank

#1995

Historical Rank

Database

#2994

World Rank

#3122

Historical Rank

computer-science Degrees

Download Badge

Computer Science

Why Is Frederik Nevens Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Frederik Nevens's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Telaprevir for retreatment of HCV infection. (2011) (1630)
Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients. (1997) (1438)
A novel prognostic subtype of human hepatocellular carcinoma derived from hepatic progenitor cells (2006) (896)
Early use of TIPS in patients with cirrhosis and variceal bleeding. (2010) (844)
A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis. (2016) (683)
EASL clinical practical guidelines: management of alcoholic liver disease. (2012) (570)
Systemic inflammation in decompensated cirrhosis: Characterization and role in acute‐on‐chronic liver failure (2016) (455)
Extracorporeal albumin dialysis with the molecular adsorbent recirculating system in acute‐on‐chronic liver failure: The RELIEF trial (2013) (443)
Intravenous cyclosporine versus intravenous corticosteroids as single therapy for severe attacks of ulcerative colitis. (2001) (401)
The clinicopathological and prognostic relevance of cytokeratin 7 and 19 expression in hepatocellular carcinoma. A possible progenitor cell origin (2006) (376)
Levels of alkaline phosphatase and bilirubin are surrogate end points of outcomes of patients with primary biliary cirrhosis: an international follow-up study. (2014) (346)
A histologic scoring system for prognosis of patients with alcoholic hepatitis. (2014) (337)
Development and Validation of a Scoring System to Predict Outcomes of Patients With Primary Biliary Cirrhosis Receiving Ursodeoxycholic Acid Therapy. (2015) (299)
Histological diversity in cholangiocellular carcinoma reflects the different cholangiocyte phenotypes (2012) (286)
Lamivudine therapy for chronic hepatitis B: a six-month randomized dose-ranging study. (1997) (283)
Atorvastatin lowers portal pressure in cirrhotic rats by inhibition of RhoA/Rho‐kinase and activation of endothelial nitric oxide synthase (2007) (275)
Everolimus With Reduced Tacrolimus Improves Renal Function in De Novo Liver Transplant Recipients: A Randomized Controlled Trial (2012) (275)
Acute-on-chronic liver failure in cirrhosis (2016) (258)
Glypican-3 Expression Distinguishes Small Hepatocellular Carcinomas From Cirrhosis, Dysplastic Nodules, and Focal Nodular Hyperplasia-like Nodules (2006) (249)
Effect of the molecular adsorbent recirculating system and Prometheus devices on systemic haemodynamics and vasoactive agents in patients with acute-on-chronic alcoholic liver failure (2006) (244)
Lanreotide reduces the volume of polycystic liver: a randomized, double-blind, placebo-controlled trial. (2009) (240)
Early features of acute-on-chronic alcoholic liver failure: a prospective cohort study (2010) (238)
Obeticholic acid, a farnesoid X receptor agonist, improves portal hypertension by two distinct pathways in cirrhotic rats (2014) (230)
Early administration of somatostatin and efficacy of sclerotherapy in acute oesophageal variceal bleeds: the European Acute Bleeding Oesophageal Variceal Episodes (ABOVE) randomised trial (1997) (228)
Pretransplant Predictors of Posttransplant Adherence and Clinical Outcome: An Evidence Base for Pretransplant Psychosocial Screening (2009) (225)
Embolization of large spontaneous portosystemic shunts for refractory hepatic encephalopathy: A multicenter survey on safety and efficacy (2013) (225)
Association of Adipose Tissue Inflammation With Histologic Severity of Nonalcoholic Fatty Liver Disease. (2015) (223)
GC-MS analysis of breath odor compounds in liver patients. (2008) (222)
Focal lesions in cirrhotic explant livers: Pathological evaluation and accuracy of pretransplantation imaging examinations (2002) (221)
Keratin 19: a key role player in the invasion of human hepatocellular carcinomas (2013) (216)
Efficacy of Glecaprevir/Pibrentasvir for 8 or 12 Weeks in Patients With Hepatitis C Virus Genotype 2, 4, 5, or 6 Infection Without Cirrhosis (2017) (198)
Practical Recommendations for Long-term Management of Modifiable Risks in Kidney and Liver Transplant Recipients: A Guidance Report and Clinical Checklist by the Consensus on Managing Modifiable Risk in Transplantation (COMMIT) Group (2017) (191)
Effectiveness of interferon alfa on incidence of hepatocellular carcinoma and decompensation in cirrhosis type C. European Concerted Action on Viral Hepatitis (EUROHEP). (1997) (182)
Long term clinical outcome of chronic hepatitis C patients with sustained virological response to interferon monotherapy (2004) (180)
Use of early-TIPS for high-risk variceal bleeding: results of a post-RCT surveillance study. (2012) (177)
norUrsodeoxycholic acid improves cholestasis in primary sclerosing cholangitis. (2017) (176)
Diffusion-weighted MRI provides additional value to conventional dynamic contrast-enhanced MRI for detection of hepatocellular carcinoma (2009) (169)
Review article: blood platelet number and function in chronic liver disease and cirrhosis (2008) (165)
Improvement of autoimmune hepatitis during pregnancy followed by flare-up after delivery (2002) (159)
Renal Function at Two Years in Liver Transplant Patients Receiving Everolimus: Results of a Randomized, Multicenter Study (2013) (156)
Telaprevir is effective given every 8 or 12 hours with ribavirin and peginterferon alfa-2a or -2b to patients with chronic hepatitis C. (2011) (154)
Long-term exposure to sorafenib of liver cancer cells induces resistance with epithelial-to-mesenchymal transition, increased invasion and risk of rebound growth. (2013) (152)
The FXR agonist obeticholic acid prevents gut barrier dysfunction and bacterial translocation in cholestatic rats. (2015) (152)
Blood metabolomics uncovers inflammation-associated mitochondrial dysfunction as a potential mechanism underlying ACLF. (2019) (152)
Liver regeneration in acute severe liver impairment: a clinicopathological correlation study (2006) (151)
FXR agonist obeticholic acid reduces hepatic inflammation and fibrosis in a rat model of toxic cirrhosis (2016) (151)
Safety and efficacy of oral entecavir given for 28 days in patients with chronic hepatitis B virus infection (2001) (147)
A pilot study of therapeutic vaccination with envelope protein E1 in 35 patients with chronic hepatitis C (2003) (146)
Activated intestinal macrophages in patients with cirrhosis release NO and IL-6 that may disrupt intestinal barrier function. (2013) (139)
Conversion from a calcineurin inhibitor to everolimus therapy in maintenance liver transplant recipients: A prospective, randomized, multicenter trial (2009) (137)
Stratification of hepatocellular carcinoma risk in primary biliary cirrhosis: a multicentre international study (2015) (134)
Portal hypertension: from pathophysiology to clinical practice (2005) (126)
Variceal pressure is a factor predicting the risk of a first variceal bleeding: A prospective cohort study in cirrhotic patients (1998) (124)
Patients with isolated polycystic liver disease referred to liver centres: clinical characterization of 137 cases (2011) (123)
COVID-19 in an international European liver transplant recipient cohort (2020) (117)
Preemptive‐TIPS Improves Outcome in High‐Risk Variceal Bleeding: An Observational Study (2018) (113)
Automated low flow pump system for the treatment of refractory ascites: a multi-center safety and efficacy study. (2013) (111)
Type of donor aortic preservation solution and not cold ischemia time is a major determinant of biliary strictures after liver transplantation (2001) (110)
A Randomized Phase II Study of Drug-Eluting Beads versus Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma (2011) (110)
Prometheus versus molecular adsorbents recirculating system: comparison of efficiency in two different liver detoxification devices. (2006) (110)
Expression of multidrug resistance‐associated protein 1 in hepatocellular carcinoma is associated with a more aggressive tumour phenotype and may reflect a progenitor cell origin (2008) (109)
Arsenic and non-cirrhotic portal hypertension. A report of eight cases. (1990) (108)
Diagnosis of Portal Hypertension: How and When (2001) (107)
Ursodeoxycholic acid therapy and liver transplant-free survival in patients with primary biliary cholangitis. (2019) (107)
Human pluripotent stem cell-derived hepatocytes support complete replication of hepatitis C virus. (2012) (106)
Neutrophil gelatinase-associated lipocalin is a biomarker of acute-on-chronic liver failure and prognosis in cirrhosis. (2016) (103)
Association Between Grade of Acute on Chronic Liver Failure and Response to Terlipressin and Albumin in Patients With Hepatorenal Syndrome (2018) (103)
Predictive value of liver cell dysplasia for development of hepatocellular carcinoma in patients with non‐cirrhotic and cirrhotic chronic viral hepatitis (2001) (102)
Single-center analysis of biopsy-confirmed posttransplant lymphoproliferative disorder: incidence, clinicopathological characteristics and prognostic factors (2013) (98)
In vivo gene transfer of endothelial nitric oxide synthase decreases portal pressure in anaesthetised carbon tetrachloride cirrhotic rats (2002) (97)
Acute-on-chronic liver failure: current concepts on definition, pathogenesis, clinical manifestations and potential therapeutic interventions (2011) (95)
Laminin-332 sustains chemoresistance and quiescence as part of the human hepatic cancer stem cell niche. (2016) (94)
The long‐term outcome of patients with polycystic liver disease treated with lanreotide (2012) (94)
Three-year Outcomes in De Novo Liver Transplant Patients Receiving Everolimus With Reduced Tacrolimus: Follow-Up Results From a Randomized, Multicenter Study (2015) (93)
Idiopathic noncirrhotic portal hypertension is associated with poor survival: results of a long‐term cohort study (2012) (89)
Investigating the Origin and Spread of Hepatitis C Virus Genotype 5a (2006) (89)
MELD score to predict outcome in adult patients with non‐acetaminophen‐induced acute liver failure (2007) (88)
Congenital veno‐venous malformations of the liver: Widely variable clinical presentations (2008) (88)
Long-term efficacy and safety of obeticholic acid for patients with primary biliary cholangitis: 3-year results of an international open-label extension study. (2019) (88)
Systematic review: the pathophysiology and management of polycystic liver disease (2011) (87)
Insulin resistance and response to telaprevir plus peginterferon α and ribavirin in treatment-naïve patients infected with HCV genotype 1 (2012) (86)
Efficacy of a medication adherence enhancing intervention in transplantation: The MAESTRO-Tx trial. (2017) (84)
Detoxifying Capacity and Kinetics of Prometheus® – A New Extracorporeal System for the Treatment of Liver Failure (2005) (83)
Malignancies and mortality in 200 patients with primary sclerosering cholangitis: a long‐term single‐centre study (2012) (83)
A role for asymmetric dimethylarginine in the pathophysiology of portal hypertension in rats with biliary cirrhosis (2005) (81)
The spectrum of nonadherence with medication in heart, liver, and lung tranplant patients assessed in various ways (2011) (81)
Return to Work and Social Participation: Does Type of Organ Transplantation Matter? (2010) (79)
Rebleeding and mortality risk are increased by ACLF but reduced by pre-emptive TIPS. (2020) (78)
Biochemical and histological effects of 26 weeks of glycyrrhizin treatment in chronic hepatitis C: a randomized phase II trial. (2006) (78)
Human Embryonic and Rat Adult Stem Cells with Primitive Endoderm-Like Phenotype Can Be Fated to Definitive Endoderm, and Finally Hepatocyte-Like Cells (2010) (78)
Performance of the Hepatic Encephalopathy Scoring Algorithm in a Clinical Trial of Patients With Cirrhosis and Severe Hepatic Encephalopathy (2009) (77)
Young women with polycystic liver disease respond best to somatostatin analogues: a pooled analysis of individual patient data. (2013) (76)
Prothrombin complex concentrate in the reduction of blood loss during orthotopic liver transplantation: PROTON-trial (2013) (76)
A climate of change: A transition approach for climate neutrality in the city of Ghent (Belgium) (2014) (76)
Reversal of hepatorenal syndrome in four patients by peroral misoprostol (prostaglandin E1 analogue) and albumin administration. (1990) (74)
Non-invasive liver elastography (Fibroscan) for detection of cystic fibrosis-associated liver disease. (2009) (74)
A stable model of cirrhotic portal hypertension in the rat: thioacetamide revisited (2006) (70)
Carbohydrate antigen 19‐9 is extremely elevated in polycystic liver disease (2009) (70)
Early and long-term clinical and radiological follow-up results of expanded-polytetrafluoroethylene-covered stent-grafts for transjugular intrahepatic portosystemic shunt procedures (2004) (70)
Excellent survival after liver transplantation for isolated polycystic liver disease: an European Liver Transplant Registry study (2011) (69)
Liver transplantation for polycystic liver disease (2001) (68)
Congenital Extrahepatic Portosystemic Shunts (Abernethy Malformation): An International Observational Study (2020) (68)
Usefulness of the single-operator cholangioscopy system SpyGlass in biliary disease: a single-center prospective cohort study and aggregated review (2017) (68)
Role of β3‐adrenoceptors for intrahepatic resistance and portal hypertension in liver cirrhosis (2009) (68)
Plasma collected from heparinized blood is not suitable for HCV-RNA detection by conventional RT-PCR assay. (1993) (68)
Review article: non‐biological liver support in liver failure (2006) (68)
Factors Associated With Recurrence of Primary Biliary Cholangitis After Liver Transplantation and Effects on Graft and Patient Survival. (2019) (68)
Breast Cancer Resistance Protein (BCRP/ABCG2) Is Expressed by Progenitor Cells/Reactive Ductules and Hepatocytes and Its Expression Pattern Is Influenced by Disease Etiology and Species Type: Possible Functional Consequences (2006) (68)
Prevalence and Correlates of Self-Reported Pretransplant Nonadherence with Medication in Heart, Liver, and Lung Transplant Candidates (2005) (68)
Global genotype distribution of hepatitis C viral infection among people who inject drugs. (2016) (67)
Assessment of variceal pressure by continuous non-invasive endoscopic registration: a placebo controlled evaluation of the effect of terlipressin and octreotide. (1995) (66)
The accuracy of positron emission tomography in the detection of posttransplant lymphoproliferative disorder (2013) (66)
Histological features in western patients with idiopathic non‐cirrhotic portal hypertension (2013) (65)
Plasma cystatin C is a predictor of renal dysfunction, acute‐on‐chronic liver failure, and mortality in patients with acutely decompensated liver cirrhosis (2017) (64)
Roux-en-y gastric bypass attenuates hepatic mitochondrial dysfunction in mice with non-alcoholic steatohepatitis (2014) (63)
The multicenter Belgian survey on liver transplantation for hepatocellular failure after bariatric surgery. (2010) (63)
Orchestration of Tryptophan‐Kynurenine Pathway, Acute Decompensation, and Acute‐on‐Chronic Liver Failure in Cirrhosis (2019) (62)
Fatal hepatic decompensation associated with interferon alfa. European concerted action on viral hepatitis (Eurohep). (1993) (61)
A Seven-Gene Set Associated with Chronic Hypoxia of Prognostic Importance in Hepatocellular Carcinoma (2010) (61)
Clinicopathological Features of Focal Nodular Hyperplasia-Like Nodules in 130 Cirrhotic Explant Livers (2006) (60)
Case report: hepatic artery pseudoaneurysm after liver transplantation: definitive treatment with a stent-graft after failed coil embolisation. (2005) (59)
Pro-Inflammatory Cytokines but Not Endotoxin-Related Parameters Associate with Disease Severity in Patients with NAFLD (2016) (59)
Major Coagulation Disturbances During Fractionated Plasma Separation and Adsorption (2007) (59)
Artificial liver support devices as treatment option for liver failure. (2012) (58)
Outcomes of liver transplantations using donations after circulatory death: a single-center experience. (2012) (58)
Major Hepatic Complications in Ursodeoxycholic Acid-Treated Patients With Primary Biliary Cholangitis: Risk Factors and Time Trends in Incidence and Outcome (2018) (57)
Evaluating health‐related quality of life in patients with polycystic liver disease and determining the impact of symptoms and liver volume (2014) (57)
Breath biomarkers of liver cirrhosis. (2012) (56)
Measurement of variceal pressure with an endoscopic pressure sensitive gauge: validation and effect of propranolol therapy in chronic conditions. (1996) (55)
Chemoembolization for hepatocellular carcinoma: 1-month response determined with apparent diffusion coefficient is an independent predictor of outcome. (2014) (55)
The effect of long‐term treatment with spironolactone on variceal pressure in patients with portal hypertension without ascites (1996) (55)
Effects of Early Placement of Transjugular Portosystemic Shunts in Patients With High-Risk Acute Variceal Bleeding: a Meta-analysis of Individual Patient Data. (2020) (54)
Hepatitis C virus and its genotypes in patients suffering from chronic hepatitis C with or without a cryoglobulinemia‐related syndrome (1994) (54)
Diagnosis and treatment of autoimmune hepatitis at age 65 and older (2005) (53)
Nitroflurbiprofen, a nitric oxide-releasing cyclooxygenase inhibitor, improves cirrhotic portal hypertension in rats. (2007) (52)
Fibrosis stage is an independent predictor of outcome in primary biliary cholangitis despite biochemical treatment response (2019) (52)
Milder disease stage in patients with primary biliary cholangitis over a 44‐year period: A changing natural history (2018) (52)
Combined liver and (heart-)lung transplantation in liver transplant candidates with refractory portopulmonary hypertension. (2002) (51)
Clinical aspects of incomplete septal cirrhosis in comparison with macronodular cirrhosis. (1994) (51)
1184 EXTRACORPOREAL LIVER SUPPORT WITH THE MOLECULAR ADSORBENT RECIRCULATING SYSTEM (MARS) IN PATIENTS WITH ACUTE-ON-CHRONIC LIVER FAILURE (AOCLF). THE RELIEF TRIAL (2010) (50)
Budd-Chiari syndrome (2015) (50)
Efficacy of interferon dose and prediction of response in chronic hepatitis C: Benelux study in 336 patients. (1998) (49)
Variceal pressure is a strong predictor of variceal haemorrhage in patients with cirrhosis as well as in patients with non-cirrhotic portal hypertension (1999) (49)
Treatment of decompensated viral hepatitis B-induced cirrhosis with low doses of interferon alpha. (2008) (49)
Endoscopic resection of ampullary lesions: a single-center 8-year retrospective cohort study of 91 patients with long-term follow-up (2013) (49)
Inhibition of glutamine synthetase in monocytes from patients with acute-on-chronic liver failure resuscitates their antibacterial and inflammatory capacity (2018) (48)
Low NO bioavailability in CCl4 cirrhotic rat livers might result from low NO synthesis combined with decreased superoxide dismutase activity allowing superoxide-mediated NO breakdown: A comparison of two portal hypertensive rat models with healthy controls (2003) (48)
Risk factors for bleeding and clinical implications in patients undergoing liver transplantation. (2011) (48)
Effectiveness of interferon alfa on incidence of hepatocellular carcinoma and decompensation in cirrhosis type C (1997) (47)
Septuagenarian and octogenarian donors provide excellent liver grafts for transplantation. (2012) (47)
Hepatitis C virus genotypes: distribution and clinical significance in patients with cirrhosis type C seen at tertiary referral centres in Europe (2001) (47)
Bench-to-beside review: Acute-on-chronic liver failure - linking the gut, liver and systemic circulation (2011) (46)
Detoxifying Capacity and Kinetics of the Molecular Adsorbent Recycling System (2003) (46)
Detection of hepatitis C virus antigen by immuno-histochemical staining: a histological marker of hepatitis C virus infection. (1994) (46)
Nuclear β‐catenin staining and absence of steatosis are indicators of hepatocellular adenomas with an increased risk of malignancy (2007) (45)
Quantitative hepatitis B virus DNA assessment by the limiting‐dilution polymerase chain reaction in chronic hepatitis B patients: evidence of continuing viral suppression with longer duration and higher dose of lamivudine therapy (1998) (45)
Cholestasis-induced pruritus treated with ultraviolet B phototherapy: an observational case series study. (2012) (45)
Rational Basis for Optimizing Short and Long-term Hepatitis B Virus Prophylaxis Post Liver Transplantation: Role of Hepatitis B Immune Globulin (2015) (44)
Patients with large‐duct primary sclerosing cholangitis and Crohn's disease have a better outcome than those with ulcerative colitis, or without IBD (2016) (43)
Hepatitis C virus genotypes: epidemiological and clinical associations (2008) (43)
The risk of early occurrence and recurrence of hepatocellular carcinoma in hepatitis C‐infected patients treated with direct‐acting antivirals with and without pegylated interferon: A Belgian experience (2017) (43)
Outcome of patients with hepatocellular carcinoma listed for liver transplantation within the Eurotransplant allocation system (2006) (43)
Orlistat treatment is safe in overweight and obese liver transplant recipients: a prospective, open label trial (2006) (42)
YAP and TAZ Heterogeneity in Primary Liver Cancer: An Analysis of Its Prognostic and Diagnostic Role (2019) (42)
Both Ca2+ -dependent and -independent pathways are involved in rat hepatic stellate cell contraction and intrahepatic hyperresponsiveness to methoxamine. (2007) (41)
Farnesoid X Receptor Activation Attenuates Intestinal Ischemia Reperfusion Injury in Rats (2017) (41)
Goals of Treatment for Improved Survival in Primary Biliary Cholangitis: Treatment Target Should Be Bilirubin Within the Normal Range and Normalization of Alkaline Phosphatase. (2020) (41)
Oxidative breakdown of octanoic acid is maintained in patients with cirrhosis despite advanced disease (2003) (41)
Effects of Age and Sex of Response to Ursodeoxycholic Acid and Transplant-free Survival in Patients With Primary Biliary Cholangitis. (2019) (41)
Reduction of relapse rates by 18-month treatment in chronic hepatitis C. A Benelux randomized trial in 300 patients. (2004) (40)
Lack of efficacy of an inhibitor of PDE4 in phase 1 and 2 trials of patients with nonalcoholic steatohepatitis. (2014) (40)
Combined Liver and Lung Transplantation With Extended Normothermic Lung Preservation in a Patient With End‐Stage Emphysema Complicated by Drug‐Induced Acute Liver Failure (2014) (39)
Steroid‐free immunosuppression during and after liver transplantation – a 3‐yr follow‐up report (2003) (39)
Positron emission tomography is not a reliable method for the early diagnosis of cholangiocarcinoma in patients with primary sclerosing cholangitis. (2005) (39)
Efficacy of interferon alfa-2b with or without prednisone withdrawal in the treatment of chronic viral hepatitis B. A prospective double-blind Belgian-Dutch study. (1990) (39)
Liver Phenotypes of European Adults Heterozygous or Homozygous for Pi*Z Variant of AAT (Pi*MZ vs Pi*ZZ genotype) and Non-carriers. (2020) (38)
Molecular evolutionary analysis and mutational pattern of full‐length genomes of hepatitis B virus isolated from Belgian patients with different clinical manifestations (2010) (38)
Biliary strictures after liver transplantation: risk factors and prevention by donor treatment with epoprostenol. (2009) (37)
A prospective randomized open-label crossover trial of regional citrate anticoagulation vs. anticoagulation free liver dialysis by the Molecular Adsorbents Recirculating System (2012) (37)
Aplastic anemia after transplantation for non-A, non-B, non-C fulminant hepatic failure: case report and review of the literature (2002) (36)
Stopping nucleos(t)ide analogue treatment in Caucasian hepatitis B patients after HBeAg seroconversion is associated with high relapse rates and fatal outcomes (2018) (36)
Safety and efficacy of different lanreotide doses in the treatment of polycystic liver disease: pooled analysis of individual patient data (2013) (36)
Noncirrhotic presinusoidal portal hypertension is common in cystic fibrosis–associated liver disease (2011) (36)
Liver transplantation using cavoportal transposition: an effective treatment in patients with complete splanchnic venous thrombosis. (2005) (35)
Rapid clearance of hepatitis C virus RNA in peripheral blood mononuclear cells of patients with clotting disorders and chronic hepatitis C treated with alpha‐2b interferon is not a predictor for sustained response to treatment (1994) (35)
The PDGFRα-laminin B1-keratin 19 cascade drives tumor progression at the invasive front of human hepatocellular carcinoma (2017) (35)
The effect of different doses of a bolus injection of somatostatin combined with a slow infusion on transmural oesophageal variceal pressure in patients with cirrhosis. (1994) (34)
Somatostatin analogues improve health‐related quality of life in polycystic liver disease: a pooled analysis of two randomised, placebo‐controlled trials (2015) (34)
Nodular regenerative hyperplasia, portal vein thrombosis, and avascular hip necrosis due to hyperhomocysteinaemia (2005) (34)
Hepatic immunohistochemical staining with a monoclonal antibody against HCV-E2 to evaluate antiviral therapy and reinfection of liver grafts in hepatitis C viral infection. (2003) (34)
The long-term morbidity and mortality rate in a cohort of patients with liver cirrhosis and oesophageal varices. (1995) (34)
Giant liver hemangioma: the role of female sex hormones and treatment. (2011) (33)
Belgian experience with direct acting antivirals in people who inject drugs. (2017) (33)
Endovascular shunt reduction in the management of transjugular portosystemic shunt-induced hepatic encephalopathy: preliminary experience with reduction stents and stent-grafts. (2007) (32)
Long-term impact of preventive UDCA therapy after transplantation for primary biliary cholangitis. (2020) (32)
CC‐Type chemokine receptor 5‐&Dgr;32 mutation protects against primary sclerosing cholangitis (2006) (32)
Carbon monoxide produced by intrasinusoidally located haem‐oxygenase‐1 regulates the vascular tone in cirrhotic rat liver (2009) (32)
HNF1B deficiency causes ciliary defects in human cholangiocytes (2012) (32)
The use of carbon dioxide wedged hepatic venography to identify the portal vein: comparison with direct catheter portography with iodinated contrast medium and analysis of predictive factors influencing level of opacification. (2006) (31)
A multicentre, randomized study to evaluate the safety and efficacy of histamine dihydrochloride and interferon‐α‐2b for the treatment of chronic hepatitis C (2002) (31)
Covered stents are better than uncovered stents for transjugular intrahepatic portosystemic shunts in cirrhotic patients with refractory ascites: a retrospective cohort study. (2010) (31)
O168 THE FIRST PRIMARY BILIARY CIRRHOSIS (PBC) PHASE 3 TRIAL IN TWO DECADES – AN INTERNATIONAL STUDY OF THE FXR AGONIST OBETICHOLIC ACID IN PBC PATIENTS (2014) (31)
Tolerance of Liver Transplant Patients to Strenuous Physical Activity in High‐Altitude (2004) (31)
Transcatheter arterial embolization for iatrogenic hemobilia is a safe and effective procedure: case series and review of the literature (2012) (29)
Prospective study comparing different indirect methods to measure portal pressure. (2011) (29)
Combined liver–thoracic transplantation: single‐center experience with introduction of the ‘Liver‐first’ principle (2016) (29)
Meta-analysis of individual patient data of albumin dialysis in acute-on-chronic liver failure: focus on treatment intensity (2019) (29)
The intensive care unit course and outcome in acute-on-chronic liver failure are comparable to other populations. (2018) (28)
Immunogenicity and safety of an experimental adjuvanted hepatitis B candidate vaccine in liver transplant patients (2006) (27)
Transcatheter Chemoembolization of Unresectable Hepatocellular Carcinoma: Current Knowledge and Future Directions (2009) (27)
Molecular characterization of hepatitis B virus strains circulating in Belgian patients co‐infected with HIV and HBV: Overt and occult infection (2011) (27)
Combination of fibrates with obeticholic acid is able to normalise biochemical liver tests in patients with difficult‐to‐treat primary biliary cholangitis (2021) (27)
A critical comparison of drug therapies in currently used therapeutic strategies for variceal haemorrhage (2004) (27)
Acute liver failure secondary to khat (Catha edulis)-induced necrotic hepatitis requiring liver transplantation: case report. (2011) (27)
Blood antioxidant levels in patients with alcoholic liver disease correlate with the degree of liver impairment and are not specific to alcoholic liver injury itself (2002) (27)
Expanded polytetrafluoroethylene-covered stent-grafts for transjugular intrahepatic portosystemic shunts in cirrhotic patients: Long-term patency and clinical outcome results (2017) (27)
Lanreotide Reduces Liver Volume, But Might Not Improve Muscle Wasting or Weight Loss, in Patients With Symptomatic Polycystic Liver Disease. (2015) (27)
Wilson's disease: long-term follow-up of a cohort of 24 patients treated with D-penicillamine (2010) (26)
Hepatosplenic γδ T‐cell lymphoma after liver transplantation: Report of the first 2 cases and review of the literature (2009) (26)
Phase 2 study of the combination of merimepodib with peginterferon-alpha2b, and ribavirin in nonresponders to previous therapy for chronic hepatitis C. (2007) (26)
Virological analysis of patients receiving Telaprevir administered Q8H or Q12H with Peginterferon-Alfa-2A or -Alfa-2B and Ribavirin in treatment-naive patients with Genotype I hepatitis C: study C208 (2009) (26)
High‐throughput sequencing identifies aetiology‐dependent differences in ductular reaction in human chronic liver disease (2019) (25)
Technology Experience of Solid Organ Transplant Patients and Their Overall Willingness to Use Interactive Health Technology (2018) (24)
LIVER TRANSPLANTATION USING LIVERS FROM SEPTUAGENARIAN AND OCTOGENARIAN DONORS: AN UNDERUSED STRATEGY TO REDUCE MORTALITY ON THE WAITING LIST. (2004) (24)
Early prediction of major depression in chronic hepatitis C patients during peg-interferon alpha-2b treatment by assessment of vegetative-depressive symptoms after four weeks. (2007) (24)
Development and validation of a polycystic liver disease complaint-specific assessment (POLCA). (2014) (24)
Secondary sclerosing cholangitis: an emerging complication in critically ill COVID-19 patients (2021) (23)
Resource use and cost of hepatitis C-related care (2012) (23)
Complete freedom from rejection after intestinal transplantation using a new tolerogenic protocol combined with low immunosuppression. (2002) (22)
Previous intravenous substance use and outcome of liver transplantation in patients with chronic hepatitis C infection. (2009) (22)
Measurement of Gamma Glutamyl Transferase to Determine Risk of Liver Transplantation or Death in Patients With Primary Biliary Cholangitis. (2020) (22)
CD14+ macrophages that accumulate in the colon of African AIDS patients express pro-inflammatory cytokines and are responsive to lipopolysaccharide (2015) (21)
Rapid Response to Treatment of Autoimmune Hepatitis Associated with Remission at 6 and 12 Months. (2019) (21)
Hereditary hyperferritinaemia-cataract syndrome: a challenging diagnosis for the hepatogastroenterologist. (2005) (21)
Use of the Viatorr Expanded Polytetrafluoroethylene-Covered Stent-Graft for Transjugular Intrahepatic Portosystemic Shunt Creation in Children: Initial Clinical Experience (2008) (21)
Implications of hepatitis C virus subtype 1a migration patterns for virus genetic sequencing policies in Italy (2017) (21)
Effects of varying doses of spironolactone without and with nitrates on portal vein pressure and kidney function in partial portal vein ligated rats (1996) (21)
Variable efficacy of TIPSS in the management of ectopic variceal bleeding: a multicentre retrospective study (2018) (21)
Hepatitis G virus infection in acute fulminant hepatitis: prevalence of HGV infection and sequence analysis of a specific viral strain (1998) (21)
High-frequency vagus nerve stimulation improves portal hypertension in cirrhotic rats (2011) (20)
Preoperative Arterial Embolization Facilitates Multivisceral Transplantation for Portomesenteric Thrombosis (2015) (20)
Oesophageal varices: Assessment of the risk of bleeding and mortality (2000) (20)
Human hepatic progenitor cells express vasoactive intestinal peptide receptor type 2 and receive nerve endings (2007) (20)
HBx or HCV core gene expression in HepG2 human liver cells results in a survival benefit against oxidative stress with possible implications for HCC development. (2007) (20)
Mass migration to Europe: an opportunity for elimination of hepatitis B virus? (2019) (20)
Progressive multifocal leukoencephalopathy in liver transplant recipients: a case report and review of the literature (2011) (20)
Number needed to treat with ursodeoxycholic acid therapy to prevent liver transplantation or death in primary biliary cholangitis (2019) (19)
The Molecular Adsorbent Recirculating System in patients with severe liver failure: clinical results at the K.U. Leuven. (2002) (19)
ENDURANCE-4: Efficacy and Safety of ABT-493/ABT-530 Treatment in Patients with Chronic HCV Genotype 4, 5, or 6 Infection (2016) (19)
Efficacy of interferon‐based antiviral therapy in patients with chronic hepatitis C infected with genotype 5: A meta‐analysis of two large prospective clinical trials (2011) (19)
Hepatobiliary phenotypes of adults with alpha-1 antitrypsin deficiency (2021) (19)
Resistance development after long-term sorafenib exposure in hepatocellular cancer cell lines and risk of rebound growth and epithelial to mesenchymal transition. (2012) (19)
Hepatitis C virus: the burden of the disease. (2002) (19)
Combined ‘En Bloc’ Liver and Pancreas Transplantation in Patients with Liver Disease and Type 1 Diabetes Mellitus (2004) (19)
Hepatitis C virus genotypes: epidemiological and clinical associations. Benelux Study Group on Treatment of Chronic Hepatitis C. (1998) (18)
Estrogen‐Containing Oral Contraceptives Are Associated With Polycystic Liver Disease Severity in Premenopausal Patients (2019) (18)
Dietary intervention, but not losartan, completely reverses non-alcoholic steatohepatitis in obese and insulin resistant mice (2017) (18)
Cholestatic pruritus : an update. (2019) (18)
Effects of ritanserin, a selective and specific S2‐serotonergic antagonist, on portal pressure and splanchnic hemodynamics in portal hypertensive rats (1991) (17)
Are TIPS Stent-Grafts a Contraindication for Future Liver Transplantation? (2004) (17)
Steroidal or non-steroidal FXR agonists - Is that the question? (2017) (17)
Outcome of liver transplantation for hepatopulmonary syndrome: a Eurotransplant experience (2018) (17)
Porphyria cutanea tarda and liver disease. A retrospective analysis of 17 cases from a single centre and review of the literature. (2008) (17)
Retreatment of hepatitis C non-responsive to Interferon. A placebo controlled randomized trial of Ribavirin monotherapy versus combination therapy with Ribavirin and Interferon in 121 patients in the Benelux [ISRCTN53821378] (2003) (16)
Bacterial infections in patients with acute variceal bleeding in the era of antibiotic prophylaxis. (2021) (16)
2020 position statement and recommendations of the European Liver and Intestine Transplantation Association (ELITA): management of hepatitis B virus‐related infection before and after liver transplantation (2021) (16)
Session 5: Treatment of the Acute Bleeding Episode (2007) (16)
Transcatheter arterial chemoembolization with doxorubicin-eluting superabsorbent polymer microspheres in the treatment of hepatocellular carcinoma: midterm follow-up. (2014) (16)
Severity in polycystic liver disease is associated with aetiology and female gender: Results of the International PLD Registry (2018) (16)
REFINE: A Randomized Trial Comparing Cyclosporine A and Tacrolimus on Fibrosis After Liver Transplantation for Hepatitis C (2014) (16)
Copeptin as an Indicator of Hemodynamic Derangement and Prognosis in Liver Cirrhosis (2015) (16)
Goals of Treatment for Improved Survival in Primary Biliary Cholangitis: Treatment Target Should Be Bilirubin Within the Normal Range and Normalization of Alkaline Phosphatase. (2020) (16)
Histology obtained by needle biopsy gives additional information on the prognosis of hepatocellular carcinoma (2011) (16)
PBC-transplantation and disease recurrence. (2018) (16)
Successful conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium (myfortic) in liver transplant patients with gastrointestinal side effects. (2009) (16)
P1185 INTERIM SVR12 RESULTS FROM THE TELAPREVIR PHASE 3B REPLACE STUDY IN TREATMENT-NAIVE STABLE LIVER TRANSPLANT PATIENTS WITH GENOTYPE 1 HCV INFECTION (2014) (15)
Heterozygous &agr;1-antitrypsin Z allele mutation in presumed healthy donor livers used for transplantation (2013) (15)
HCV genotype 5: epidemiology and spread of an uncommon genotype. (2008) (15)
Liver versus cardiothoracic transplant candidates and their pretransplant psychosocial and behavioral risk profiles: good neighbors or complete strangers? (2007) (15)
Daily induction combination treatment with alpha 2b interferon and ribavirin or standard combination treatment in naive chronic hepatitis C patients. A multicentre randomized controlled trial * (2003) (15)
Benelux multicentre trial of alpha interferon treatment for chronic hepatitis C: standard v high dose treatment monitored by biochemical and virological markers (interim analysis). Benelux Multicentre Trial Study Group. (1993) (15)
Donor Hepatectomy and Implantation Time Are Associated With Early Complications After Liver Transplantation: A Single-center Retrospective Study. (2020) (15)
The influence of laboratory‐induced MELD score differences on liver allocation: more reality than myth (2012) (14)
Should the law on anonymity of organ donation be changed? The perception of liver transplant recipients (2009) (14)
Non-invasive alloimmune risk stratification of long-term liver transplant recipients. (2021) (14)
TT virus infection in acute and chronic liver diseases and in patients regularly receiving blood products in Belgium. (2004) (14)
Treatment of non-alcoholic fatty liver disease: can we already face the epidemic? (2013) (14)
Eight Weeks Treatment With Glecaprevir/Pibrentasvir Is Safe and Efficacious in an Integrated Analysis of Treatment-Naïve Patients With Hepatitis C Virus Infection. (2020) (14)
The effect of mycophenolate mofetil on hepatitis B viral load in stable renal transplant recipients with chronic hepatitis B. (2001) (14)
The molecular adsorbent recycling system (MARS) and transmembrane transport of albumin‐bound toxins (2005) (13)
Comparison of perceived health status among solid organ transplant candidates (2010) (13)
High discontinuation rate of azathioprine in autoimmune hepatitis, independent of time of treatment initiation (2020) (13)
Factors Associated With Progression and Outcomes of Early-stage Primary Biliary Cholangitis. (2020) (13)
Use of a Commercially Available Line Probe Assay for Genotyping of Hepatitis C Virus 5a Strains (2005) (13)
Ethyl Glucuronide in Hair Is an Accurate Biomarker of Chronic Excessive Alcohol Use in Patients With Alcoholic Cirrhosis (2017) (13)
Immune reactivity to β-tubulin isotype 5 and vesicular integral-membrane protein 36 in patients with autoimmune gastrointestinal disorders (2010) (13)
492 A phase II, placebo-controlled study of merimepodib (XV-497), in combination with pegylated interferon-alfa, and ribavirin in patients with chronic hepatitis C non-responsive to previous therapy with interferon-alfa and ribavirin (2004) (13)
Halofuginone can worsen liver fibrosis in bile duct obstructed rats (2004) (13)
Acute ataxic neuropathy associated with hepatitis E virus infection (2015) (13)
Eliminating viral hepatitis C in Belgium: the micro-elimination approach (2020) (13)
Combined or Serial Liver and Lung Transplantation for Epithelioid Hemangioendothelioma: A Case Series (2015) (12)
Liver stiffness measurement by vibration-controlled transient elastography improves outcome prediction in primary biliary cholangitis. (2022) (12)
Characterization of a cell culture model for clinically aggressive hepatocellular carcinoma induced by chronic hypoxia. (2012) (12)
P245 ROUX-EN-Y GASTRIC BYPASS ATTENUATES HEPATIC MITOCHONDRIAL DYSFUNCTION IN MICE WITH NONALCOHOLIC STEATOHEPATITIS (2014) (12)
992 AN EARLY DECISION FOR PTFE-TIPS IMPROVES SURVIVAL IN HIGH RISK CIRRHOTIC PATIENTS ADMITTED WITH AN ACUTE VARICEAL BLEEDING. A MULTICENTER RCT (2008) (12)
Center is an important indicator for choice of invasive therapy in polycystic liver disease (2017) (12)
56 ON-TREATMENT RESPONSE-GUIDED THERAPY WITH TELAPREVIR Q8H OR Q12H COMBINED WITH PEGINTERFERON ALFA-2A OR PEGINTERFERON ALFA-2B AND RIBAVIRIN IN TREATMENT-NAIVE GENOTYPE 1 HEPATITIS C (STUDY C208) (2010) (12)
NO Synthase in the Liver: Prospects of in vivo Gene Transfer (1998) (12)
Norursodeoxycholic Acid Improves Cholestasis in Primary Sclerosing Cholangitis: Results of a Phase II Dose Finding Study (2016) (12)
A near-full length genotypic assay for HCV1b. (2014) (12)
Prevention of hepatic encephalopathy by administration of rifaximin and lactulose in patients with liver cirrhosis undergoing placement of a transjugular intrahepatic portosystemic shunt (TIPS): a multicentre randomised, double blind, placebo controlled trial (PEARL trial) (2020) (11)
Acute hepatitis B notification rates in Flanders, Belgium, 2009 to 2017 (2019) (11)
Efficacy and Safety of Everolimus With Reduced Tacrolimus in Liver Transplant Recipients: 24-month Results From the Pooled Analysis of 2 Randomized Controlled Trials (2020) (11)
Prometheus versus MARS: Comparison of efficiency in two different liver detoxification devices (2005) (11)
International Multi-Specialty Delphi Survey: Identification of Diagnostic Criteria for Hepatic and Renal Cyst Infection (2016) (11)
Multiple Solid Organ Transplantation in Telomeropathy: Case Series and Literature Review (2018) (11)
Confirmatory strategy of hepatitis C serology based on two screening assays in a diagnostic setting. (1997) (11)
Glycome Patterns of Perfusate in Livers Before Transplantation Associate With Primary Nonfunction. (2018) (11)
GS-02-Efficacy of GKT831 in patients with primary biliary cholangitis and inadequate response to ursodeoxycholic acid: Interim efficacy results of a phase 2 clinical trial (2019) (11)
61 FACTORS INFLUENCING PROGRESSION OF LIVER FIBROSIS IN PATIENTS WITH CHRONIC HEPATITIS C: RESULTS OF THE 3-YEAR T2S-918-HCV STUDY WITH HCVE1 THERAPEUTIC VACCINATION (2008) (11)
Clinical relevance of plasma virome dynamics in liver transplant recipients (2020) (11)
Recommendations on the Diagnosis and Initial Management of Acute Variceal Bleeding and Hepatorenal Syndrome in Patients with Cirrhosis (2019) (10)
A phase II study of human allogeneic liver-derived progenitor cell therapy for acute-on-chronic liver failure and acute decompensation (2021) (10)
Surgical strategy in liver transplantation for polycystic liver disease. (2001) (10)
Noncutaneous head and neck cancer in solid organ transplant patients: single center experience. (2014) (10)
Profiling the patient with autoimmune hepatitis on calcineurin inhibitors: a real-world-experience (2019) (10)
P1184 : Age, bilirubin and albumin, regardless of sex, are the strongest independent predictors of biochemical response and transplantation-free survival in patients with primary biliary cirrhosis (2015) (10)
Cholestatic liver disease in long‐term infantile nephropathic cystinosis (2008) (10)
Clinical trial: a randomized trial of pegylated‐interferon‐α‐2a plus ribavirin with or without amantadine in treatment‐naïve or relapsing chronic hepatitis C patients (2009) (10)
Exploring resistance pathways for first-generation NS3/4A protease inhibitors boceprevir and telaprevir using Bayesian network learning. (2017) (10)
Successful application of endoscopic ultrasound-guided fine needle biopsy to establish pancreatic patient-derived tumor xenografts: a pilot study (2016) (10)
Caucasian Ethnicity, but Not Treatment Cessation Is Associated with HBsAg Loss Following Nucleos(t)ide Analogue-Induced HBeAg Seroconversion (2019) (9)
Frequency of the CCR5-Δ32 Mutant Allele Is Not Increased in Belgian Hepatitis C Virus-Infected Patients (2005) (9)
Percutaneous shunt reduction for the management of TIPS-induced acute liver decompensation: A follow-up study. (2016) (9)
Age Matching of Elderly Liver Grafts With Elderly Recipients Does Not Have a Synergistic Effect on Long-term Outcomes When Both Are Carefully Selected (2019) (9)
A Global Risk Score (GRS) to Simultaneously Predict Early and Late Tumor Recurrence Risk after Resection of Hepatocellular Carcinoma1 (2016) (9)
Polycystic liver disease genes: practical considerations for genetic testing. (2021) (9)
Outcomes of long-term administration of intravenous hepatitis B immunoglobulins for the prevention of recurrent hepatitis B after liver transplantation. (2010) (9)
Hair ethyl glucuronide and serum carbohydrate deficient transferrin for the assessment of relapse in alcohol-dependent patients. (2016) (9)
Screening for hepatitis C at the emergency department: Should babyboomers also be screened in Belgium? (2018) (9)
Diagnostic Accuracy of Biomarkers of Alcohol Use in Patients With Liver Disease: A Systematic Review (2020) (9)
Cirrhotic portal hypertension: current and future medical therapy for primary and secondary prevention of variceal bleeding. (2006) (9)
SHOULD CHRONIC HEPATITIS B BE TREATED AS EARLY AS POSSIBLE? (2013) (9)
Pre‐operative trans‐catheter arterial chemo‐embolization increases hepatic artery thrombosis after liver transplantation – a retrospective study (2018) (9)
Variceal band ligation in the management of bleeding oesophageal varices: an overview. (2001) (9)
Everolimus halts hepatic cystogenesis in a rodent model of polycystic-liver-disease (2017) (8)
Relapse after treatment with peginterferon α-2b alone or in combination with lamivudine in HBeAg positive chronic hepatitis B (2007) (8)
Progression of liver fibrosis in HCV‐positive liver transplant recipients randomized to everolimus with reduced calcineurin inhibitor (CNI) therapy or a standard CNI regimen (2015) (8)
Selection criteria and outcome of patients referred to intestinal transplantation: an European center experience. (2006) (8)
Assessing testing rates for viral hepatitis B and C by general practitioners in Flanders, Belgium: a registry-based study (2019) (8)
Resource Analysis of Somatostatin in the Treatment of Bleeding Esophageal Varices (1999) (8)
Obeticholic Acid in Primary Biliary Cholangitis. (2016) (8)
Bilateral simultaneous anterior ischemic optic neuropathy, an extrahepatic manifestation of hepatitis C cured with direct acting antivirals (2016) (8)
A Comparison of Prognostic Scores (Mayo, UK-PBC, and GLOBE) in Primary Biliary Cholangitis. (2021) (8)
Session 2 ‒ Diagnosis of Portal Hypertension: How and When (2008) (8)
Hepatitis C: screening, treatment and prevention practical guidelines. (2003) (8)
EASL Clinical Practice Guidelines on management of Cystic Liver Diseases. (2022) (8)
Definition of Key Events: Let's Try Again (2000) (8)
Influence of tips on development of hepatocellular carcinoma in cirrhosis (2005) (8)
Validation of hepatitis C virus RNA detection using capillary blood by finger prick (GenXpert system)—Hepatitis C fingerprick study (2020) (8)
Drug holiday in patients with polycystic liver disease treated with somatostatin analogues (2018) (7)
Renal function with everolimus and reduced tacrolimus in de novo liver transplant recipients: 12 month results of the H2304 trial. O-17 (2012) (7)
Improved Markers of Cholestatic Liver Injury in Patients With Primary Biliary Cholangitis Treated With Obeticholic Acid and Bezafibrate (2020) (7)
Effectiveness and tolerability of pegylated interferon alfa-2b in combination with ribavirin for treatment of chronic hepatitis C: the PegIntrust study. (2010) (7)
Standard cyclosporine A-based versus completely steroid-free FK506-based immunosuppression after liver transplantation. (2001) (7)
Impact of Acute-on-Chronic Liver Failure on response to treatment with terlipressin and albumin in patients with type 1 hepatorenal syndrome (2017) (7)
Greater Transplant-free Survival in Patients Receiving Obeticholic Acid for Primary Biliary Cholangitis in a Clinical Trial Setting Compared to Real-World External Controls. (2022) (7)
Non-invasive variceal pressure measurements: validation and clinical implications. (1996) (7)
Another case of acute renal failure (ARF) due to acute tubular necrosis (ATN), proven by renal biopsy in non-fulminant hepatitis A virus (HAV) infection. (1997) (7)
Patients infected with HCV-5 present the same response rate as patients infected with HCV-1: Results from the Belgian randomised trial for naive and relapsers (BERNAR-1) (2005) (7)
ADP‐degrading enzymes inhibit platelet activation in bile duct‐ligated rats (2010) (7)
Prevalence and risk factors of hepatitis B virus infection in Middle‐Limburg Belgium, year 2017: Importance of migration (2019) (7)
Intravenous cyclosporine (CyA) monotherapy versus intravenous methylprednisolone (MP) monotherapy in severe ulcerative colitis: A randomized, double blind controlled trial (1998) (7)
A randomized, open-label, multicenter study evaluating the efficacy of peginterferon alfa-2a versus interferon alfa-2a, in combination with ribavirin, in naïve and relapsed chronic hepatitis C patients. (2010) (7)
Genotype, serum level of HCV-RNA and response to interferon-alpha treatment in patients with chronic hepatitis C. (1995) (7)
Measurement of variceal pressure and its clinical implications. (1994) (6)
Testing the Efficacy of a Multicomponent Theory-Based Tailored Behavioral Medication Adherence Intervention in Transplantation: The MAESTRO-TX RCT (2016) (6)
Hepatitis C genotype 4 response rate to pegylated interferon and ribavirin treatment in Belgium is similar to genotype 1. (2010) (6)
Elimination of hepatitis C virus infection in patients with haemophilia in Belgium: A single‐centre experience (2019) (6)
Pharmacokinetic Interactions between Simeprevir and Ledipasvir in Treatment-Naive Hepatitis C Virus Genotype 1-Infected Patients without Cirrhosis Treated with a Simeprevir-Sofosbuvir-Ledipasvir Regimen (2017) (6)
TIPS for refractory ascites a Belgian two center experience (1996) (6)
A multicentre retrospective analysis on growth of residual hepatocellular adenoma after resection (2020) (6)
Transplantation osteoporosis and corticosteroid-induced osteoporosis in autoimmune diseases: experience with alfacalcidol (2000) (6)
Thrombosis of a portal vein aneurysm: a case report with literature review (2018) (6)
Effect of MARS and PROMETHEUS on systemic hemodynamics and vasoactive agents in patients with acute on-chronic alcoholic liver failure: the clash of the titans (2005) (6)
HCV genotype distribution in Flanders and Brussels (Belgium): unravelling the spread of an uncommon HCV genotype 5a cluster (2010) (6)
Liver transplantation during the COVID-19 epidemic : recommendations from the Belgian Liver Intestine Transplant Committee (BeLIAC). (2020) (6)
Renal disease in the allograft recipient. (2020) (5)
Behavioral Patterns of Total Serum Bilirubin Prior to Major Clinical Endpoints in 3529 Patients with Primary Biliary Cholangitis (2016) (5)
Liver-Related and Cardiovascular Outcome of Patients Transplanted for Nonalcoholic Fatty Liver Disease: a European Single-Center Study. (2021) (5)
Hepatocytic differentiation in cholangiocellular carcinoma suggesting hepatic progenitor cell origin (2008) (5)
Personalized subcutaneous administration of hepatitis B surface antibodies without nucleos(t)ide analogs for patients at risk of renal failure after liver transplantation: a prospective single center cohort study (2018) (5)
Peginterferon alpha-2a (40kDa) plus ribavirin is as effective in patients relapsing after conventional interferon based therapy as in naive patients: Results from the Bernar-1 trial (2005) (5)
Early administration of somatostatin and efficacy of sclerotherapy in acute oesophageal variceal bleeds: the European Acute Bleeding Oesophageal Variceal (ABOVE) randomised trial (1998) (5)
The RANTES −28 g polymorphism is associated with primary sclerosing cholangitis (2007) (5)
Treatment of severe alcoholic hepatitis: A systematic review. (2021) (5)
Transjugular Intrahepatic Portosystemic Shunt for the Treatment of Portal Hypertension-Induced Refractory Ascites Due to Metastatic Carcinomatous Liver Disease. (2018) (5)
Is there a role for neuregulin 4 in human nonalcoholic fatty liver disease? (2021) (5)
Alkaline phosphatase predicts response in polycystic liver disease during somatostatin analogue therapy: a pooled analysis (2016) (5)
Belgian experience with triple therapy with boceprevir and telaprevir in genotype 1 infected patients who inject drugs (2016) (5)
norUrsodeoxycholic acid (norUDCA) improves cholestasis in primary sclerosing cholangitis (PSC) independent of ursodeoxycholic acid (UDCA) pre-treatment and response (2016) (5)
182 EFFECT OF M0002, A NOVEL V2 ANTAGONIST ON SODIUM LEVELS AND WEIGHT GAIN AFFECTED BY WATER ACCUMULATION IN CIRRHOTIC PATIENTS WITH ASCITES (2009) (5)
Fishing in the thoracic organ donor pool: What next if the catch of the day got infected with hepatitis C virus? (2019) (5)
Bilirubin is predictive of transplant-free survival even within the normal range in primary biliary cholangitis patients (2017) (5)
Phase 2 study of Telaprevir administered Q8 or Q12H with Peginterferon-Alfa-2A or Alfa-2B and ribavirin in treatment-naive subjects with genotype 1 hepatitis C: week 4 interim results (2008) (5)
Neutrophilic reversible airways dysfunction after liver transplantation: a case report. (2011) (5)
Sustained off‐treatment viral control is associated with high hepatitis B surface antigen seroclearance rates in Caucasian patients with nucleos(t)ide analogue–induced HBeAg seroconversion (2019) (5)
Primary sclerosing cholangitis complicated by amyloid A amyloidosis: complete regression of the nephrotic syndrome by liver transplantation. (2010) (5)
Percutaneous hydrodynamic thrombectomy of acute thrombosis in transjugular intrahepatic portosystemic shunt (TIPS): A feasibility study in five patients (1997) (5)
An Unusual Case of Rectal Perforation after Liver Transplantation (2012) (5)
Validation of immunohistochemical staining with the monoclonal antibody 17H10 in liver biopsies for the diagnosis of chronic hepatitis C (2000) (5)
66 GROWTH OF LIVER VOLUME STOPS AFTER ONE YEAR OF LANREOTIDE IN PATIENTS WITH POLYCYSTIC LIVERS (2010) (4)
Alpers syndrome presenting with anatomopathological features of fulminant autoimmune hepatitis (2010) (4)
Differential effect of IFN alpha-2B and ribavirin on the HCV-RNA level in primary cultures of human hepatocytes derived from chronic HCV carriers and of human hepatocytes infected in vitro (1998) (4)
Kinetic Analyses of Antiviral Suppression by NS5A Inhibitors Reveal Early and Potent Inhibition of Viral Assembly and Release of Infectious Virus The rs2294918 K434E PNPLA3 Polymorphism is associated with Nonalcoholic Fatty Liver and Steatohepatitis (2013) (4)
De novo Malignancy and Recurrent Alcoholic Cirrhosis Account for 70% of Deaths in Patients Transplanted for End-Stage Alcoholic Liver Disease (2016) (4)
1395 THE REDUCTION IN LIVER VOLUME IN POLYCYSTIC LIVER DISEASE WITH LANREOTIDE IS DOSE DEPENDENT AND IS MOST PRONOUNCED IN PATIENTS WITH THE HIGHEST LIVER VOLUME (2012) (4)
Efficacy of telaprevir-based therapy in stable liver transplant patients with chronic genotype 1 hepatitis C. (2016) (4)
The hepatitis C cascade of care in the Belgian HIV population: One step closer to elimination. (2021) (4)
Prednisolone or Pentoxifylline for Alcoholic Hepatitis. (2015) (4)
Asymmetric dimethylargine (ADMA) is involved in portal hypertension of biliary but not of toxic cirrhotic rats (2005) (4)
Double-blind, placebo-controlled study of satavaptan in the management of recurrent ascites: the spare-1 study (2009) (4)
Hepatitis B virus prevalence in first‐time blood donors in Flanders, Belgium: Impact of universal vaccination and migration (2021) (4)
Budd-Chiari syndrome: reassessment of a step-wise treatment strategy. (2015) (4)
Who to screen for hepatitis C? A cost-effectiveness study in Belgium of comprehensive hepatitis C screening in four target groups. (2019) (4)
Reply to: "Development and validation of a polycystic liver disease complaint-specific assessment (POLCA) - use of the Delphi technique for content validation". (2015) (4)
GS-18-Preventive administration of ursodeoxycholic acid after liver transplantation for primary biliary cholangitis prevents disease recurrence and prolongs graft survival (2019) (4)
Development and validation of a prognostic score for long‐term transplant‐free survival in autoimmune hepatitis type 1 (2021) (4)
UEG Week 2016 Poster Presentations (2016) (4)
Viral clade is associated with severity of symptomatic genotype 3 Hepatitis E virus infections in Belgium, 2010-2018. (2022) (4)
Efficacy, safety and pharmacokinetics of simeprevir and TMC647055/ritonavir with or without ribavirin and JNJ-56914845 in HCV genotype 1 infection (2017) (4)
Case Management to Improve Uptake for Screening and Therapy of Hepatitis C viral infection in People Who Inject Drugs (2016) (4)
Ursodeoxycholic acid treatment is associated with prolonged transplant-free survival in primary biliary cholangitis – even in patients without biochemical improvements (2018) (4)
Treatment of acute esophageal variceal bleeding: a review (1999) (4)
O132 EFFECTIVE STRATIFICATION OF HEPATOCELLULAR CARCINOMA RISK IN PRIMARY BILIARY CIRRHOSIS: RESULTS OF A MULTI-CENTRE INTERNATIONAL STUDY (2014) (4)
Everolimus Based Immunosuppression in Hepatitis C Virus Positive De Novo Liver Transplant Recipients: 24 Month Results from a Randomized Controlled Trial (2013) (3)
Correction to 'Blood metabolomics uncovers inflammation-associated mitochondrial dysfunction as a potential mechanism underlying ACLF' [J Hepatol 2020 (72) 688-701]. (2020) (3)
O74 URINARY NEUTROPHIL GELATINASE-ASSOCIATED LIPOCALIN (NGAL) IS A STRONG PREDICTOR OF SHORT-TERM OUTCOME IN PATIENTS WITH ACUTE DECOMPENSATION OF CIRRHOSIS. RELATIONSHIP WITH ACUTE-ON-CHRONIC LIVER FAILURE (ACLF) (2014) (3)
83 HISTOLOGICAL DIVERSITY IN CHOLANGIOCELLULAR CARCINOMA SUGGESTING DIFFERENT CELLS OF ORIGIN: INTRAHEPATIC PROGENITOR CELLS VERSUS HILAR MUCIN PRODUCING CELLS (2011) (3)
Long-term efficacy and safety of obeticholic acid in patients with PBC from the POISE trial grouped biochemically by risk of disease progression (2021) (3)
In vivo gene transfer of NO synthase reduces portal pressure in experimental cirrhosis in rats (1996) (3)
30 ACUTE LIVER FAILURE: CURRENT EUROPEAN PERSPECTIVE (2010) (3)
On-site testing and case management to improve hepatitis C care in drug users: a prospective, longitudinal, multicenter study in the DAA era (2021) (3)
International Multi-Specialty Delphi Survey: Identification of Diagnostic Criteria for Hepatic and Renal Cyst Infection. (2016) (3)
Patients transplanted for hepatitis C should not receive livers from older donors (2001) (3)
Outcome in Caucasian patients with hepatitis B e antigen negative chronic infection: A long‐term observational cohort study (2020) (3)
Rescue of a marginal liver graft by sequential treatment with molecular adsorbent recirculating system and transjugular intrahepatic portosystemic shunt: a case report. (2009) (3)
Impact of Acute-on-Chronic Liver Failure (ACLF) on response to treatment with terlipressin and albumin in patients with type 1 hepatorenal syndrome (2017) (3)
Treatment of recurrent severe hepatic encephalopathy in patients with large porto-collaterals shunts or transjugular portosystemic shunt. (2020) (3)
OC-030 Effective Stratification Of Hepatocellular Carcinoma Risk In Primary Biliary Cirrhosis: Results Of A Multi-centre International Study (2014) (3)
Novel Approaches to Reducing the Risk of Variceal Hemorrhage (2017) (3)
T2003 On-Treatment Response-Guided Therapy With Telaprevir Q8h or Q12h Combined With Peginterferon Alfa-2a or Peginterferon Alfa-2B and Ribavirin in Treatment-NaïVE Genotype 1 Hepatitis C (Study C208) (2010) (3)
Frequency of the CCR5-Delta32 mutant allele is not increased in Belgian hepatitis C virus-infected patients. (2005) (3)
Ductular bilirubinostasis predicts the evolution to acute-on-chronic liver failure in patients suspected with severe alcoholic steatohepatitis (2014) (3)
Primary biliary cholangitis as a roadmap for the development of novel treatments of cholestatic liver diseases. (2022) (3)
The GLOBE score identifies PBC patients at increased risk of liver transplantation or death during follow-up (2016) (3)
The GLOBE score identifies PBC patients at increased risk of liver transplantation or death in different age-categories over time (2017) (3)
Efficacy and Safety of Everolimus With Reduced Tacrolimus in De Novo Liver Transplant Recipients: Long-Term Results From the H2304E1 Study.: Abstract# A430 (2014) (3)
A rare case of HBV genotype fluctuation (shifting and reversion) after liver transplantation. (2015) (3)
657 The First New Trials for Primary Biliary Cirrhosis in a Decade: An International Program Evaluating the Farnesoid X Receptor Agonist Obeticholic Acid (2015) (3)
Prophylaxis of first variceal bleeding. (2004) (3)
Comparison of dialysis efficiency in two different liver detoxification devices: MARS versus Prometheus (2005) (2)
189 Improvement in systemic hemodynamics after mars is associated with a decrease in vasoactive substances in patients with acute on chronic liver failure (AOCLF): Results of a randomised trial (2004) (2)
Chronic Hypoxia Emerging as One of the Driving Forces behind GeneExpression and Prognosis of Hepatocellular Carcinoma (2011) (2)
Daily induction combination treatment with alfa2b interferon or standard combination treatment in naive chronic hepatitis C patients. A controlled multicenter randomized trail. (2000) (2)
Liver transplant‐free survival according to alkaline phosphatase and GLOBE score in patients with primary biliary cholangitis treated with ursodeoxycholic acid (2022) (2)
Hepatic stellate cell contraction: (myo)fibroblast-like or smooth muscle cell-like? (2005) (2)
Antifibrotic activity correlates with immune response to E1 therapeutic vaccination in 24 patients with chronic active hepatitis C (2003) (2)
Levels of Alkaline Phosphatase and Bilirubin are Surrogate Endpoints of Outcomes of Patients with Primary Biliary Cirrhosis – an International Follow-up Study Short title : Alkaline phosphatase and bilirubin as surrogate endpoints in PBC (2014) (2)
Detection of HCV antigen by immunohistochemical staining: a histological marker of HCV infection (1991) (2)
Nitroflurbiprofen (HCT-1026), a nitric oxidereleasing cyclooxygenase-inhibitor, improves cirrhotic portal hypertension in the rat without major side-effects (2006) (2)
Time-dependent factors associated with diminished transplant-free survival in patients with primary biliary cholangitis and an optimal response to ursodeoxycholic acid after one year of treatment (2017) (2)
Simplified care-pathway selection for nonspecialist practice: the GLOBAL Primary Biliary Cholangitis Study Group Age, Bilirubin, Alkaline phosphatase risk assessment tool (2020) (2)
Systematic Review: Diagnostic Accuracy of Biomarkers of Alcohol Use in Patients with Liver Disease. (2020) (2)
15 TELAPREVIR (TVR) q8h OR q12h COMBINED WITH EITHER PEGINTERFERON (PEG-IFN, P) ALFA-2A OR ALFA-2B AND RIBAVIRIN (RBV, R) IN TREATMENT-NAÏVE GENOTYPE 1 HEPATITIS C: FINAL RESULTS OF THE RANDOMIZED, OPEN-LABEL, MULTICENTER PHASE 2 STUDY C208 (2010) (2)
Recurrence of primary biliary cholangitis after liver transplantation affects graft survival : a multi-center study from the Global PBC study group (2017) (2)
Liver Transplantation for Porto-Sinusoidal Vascular Liver Disorder: Long-term Outcome. (2022) (2)
180 EVEROLIMUS-BASED IMMUNOSUPPRESSION IN HCV POSITIVE DE NOVO LIVER TRANSPLANT RECIPIENTS: 24-MONTH RESULTS OF A RANDOMIZED CONTROLLED TRIAL (2013) (2)
Combination therapy of nitrates and spironolactone in experimental portal hypertension (1995) (2)
A long-term study of liver-related events in Caucasian hepatitis B patients with normal ALT values and high viremia. (2022) (2)
Dynamic MR perfusion measurements before and after TIPS in cirrhotic patients with refractory ascites. (2007) (2)
LIVER TRANSPLANTATION IN ISOLATED POLYCYSTIC LIVER DISEASE (2009) (2)
A non-interventional phase IV Belgian survey to assess the antiviral effectiveness of pegylated interferon-alpha-2b and ribavirin treatment according to the stage of liver fibrosis in previously untreated patients with genotype 1/4/5/6 chronic hepatitis C (PRACTICE). (2014) (2)
Morbidity and mortality in compensated cirrhosis type C: relationship to interferon alpha therapy (1997) (2)
Alkaline phosphatase normalization is associated with a decreased risk for liver transplantation and death in patients with primary biliary cholangitis (2018) (2)
Immunogenicity and safety of a novel adjuvanted hepatitis B candidate vaccine in liver transplant patients (2004) (2)
Ursodeoxycholic acid improves cholestasis in primary sclerosing cholangitis (2017) (2)
Protocol for a randomized controlled multicenter trial assessing the efficacy of leuprorelin for severe polycystic liver disease: the AGAINST-PLD study (2022) (2)
Management of Acute Variceal Bleeding in Patients with Cirrhosis: General Management, Drug Therapy, and Endoscopic Treatment (2016) (2)
The Role of Brown Adipose Tissue in the Development and Treatment of Nonalcoholic Steatohepatitis: An Exploratory Gene Expression Study in Mice (2020) (2)
Enhanced co-experession of eNOS and iNOS in dilated sinusoids in advanced primary biliary cirrhosis, suggests a role for these NOS isoforms in intrahepatic portohepatic blood shunting (2000) (2)
Efficacy and safety of everolimus with early reduction or elimination of tacrolimus in 719 de novo liver transplant recipients: 12 month results of a phase iii, randomized, controlled study (2011) (2)
De novo malignancy is the major cause of death in patients transplanted for alcoholic liver disease (2013) (2)
Fractionated plasma separation and adsorption in acute-on-chronic liver failure patients results in loss of pro and anticoagulant factors (2007) (2)
Everolimus with reduced tacrolimus exposure versus standard tacrolimus in hepatitis C virus positive de novo liver transplant recipients. O-56. (2012) (2)
Telemedicine based remote monitoring after liver transplantation: Feasible in a select group and a more stringent control of immunosuppression (2021) (2)
O2 OBETICHOLIC ACID, A FARNESOID-X RECEPTOR AGONIST, REDUCES BACTERIAL TRANSLOCATION AND RESTORES INTESTINAL PERMEABILITY IN A RAT MODEL OF CHOLESTATIC LIVER DISEASE (2014) (2)
Improvement in liver histology after 3 years of E1 therapeutic vaccination in 23 patients with chronic hepatitis C (2004) (2)
Different expression of NO synthase in human cirrhotic liver specimens may be related to different mechanisms of portal hypertension (1996) (2)
nor Ursodeoxycholic acid improves cholestasis in primary sclerosing cholangitis (2017) (2)
Laboratory meld-based allocation of liver grafts: is the "sickest first" principle justified? (2011) (2)
Outcome of western patients with idiopathic non-cirrhotic portal hypertension (INCPH) is not determined by complications of portal hypertension: results of a large observational study (2010) (1)
Treatment for chronic hepatitis B: interferon what we have learned after so many years? (2000) (1)
Sarcopenia in patients with symptomatic polycystic liver disease: a more objective parameter for liver allocation? (2012) (1)
Arsenic and non-cirrhotic portal hypertension: report of 8 cases (1990) (1)
Efficacy and Safety of Everolimus With Reduced Tacrolimus in De Novo Liver Transplant Recipients: Long-Term Results From the H2304E1 Study (2014) (1)
551 OPTIMAL TIMING OF ENDOSCOPY IS ASSOCIATED WITH LOWER 42-DAY MORTALITY IN VARICEAL BLEEDING (2019) (1)
Everolimus with early reduction or elimination of tacrolimus in 719 de novo liver transplant recipients - 12 month efficacy and safety results from the H2304 study (2012) (1)
Which factors determine intention to register as a donor? A comprehensive theory-based analysis in adolescents (2008) (1)
52 DESCRIPTION OF AN AUTOMATED LOW-FLOW ASCITES (ALFA) PUMP SYSTEM FOR THE TREATMENT OF REFRACTORY ASCITES IN PATIENTS WITH CIRRHOSIS. PRELIMINARY REPORT (2012) (1)
Repetitive episodes of cryptogenic septicaemia in a patient with cirrhosis: a case of "heavy metal". (2011) (1)
In the CCL4 cirrhosis but not prehepatic portal hypertension or biliary cirrhosis, a reduced expression of ceNOS is found in rat liver (2000) (1)
Hepatitis C virus genotype and clinical outcome of compensated cirrhosis type C (1998) (1)
Multicenter Belgian experience of sofosbuvir medical need program in pre and post liver transplantation: safety and efficacy results (2015) (1)
Optimal management of bleeding oesophageal varices: The role of pharmacotherapy (1998) (1)
ELECTRONIC MONITORING FEEDBACK AND MOTIVATIONAL INTERVIEWING IMPROVES MEDICATION ADHERENCE IN HEART, LIVER AND LUNG TRANSPLANT PATIENTS: RESULTS FROM THE MAESTRO-TX RCT (2015) (1)
654 A NEW CLASSIFICATION OF PRIMARY LIVER CARCINOMAS BASED ON THEIR POSSIBLE CELLULAR ORIGIN (2013) (1)
A43 LONG-TERM EFFICACY AND SAFETY OF OBETICHOCLIC ACID IN PRIMARY BILIARY CHOLANGITIS: RESPONDER ANALYSIS OF OVER 5 YEARS OF TREATMENT IN THE POISE TRIAL (2021) (1)
Type of aortic preservation solution and not cold ischemia is a major determinant of biliary stricture (BS) after liver transplantation (LTx) (1999) (1)
Ten years countdown to hepatitis C elimination in Belgium: a mathematical modeling approach (2022) (1)
Hepatic encephalopathy is not a contraindication to pre-emptive TIPS in high-risk patients with cirrhosis with variceal bleeding (2022) (1)
Liver Transplantation Using Cavo-Portal Hemitransposition in Case of Complete Splanchnic Venous Thrombosis. (2010) (1)
Survival and prognostic indicators in cryptogenic compensated cirrhosis: a multicenter study (1995) (1)
Combined liver/thoracic transplantation: single-center experience (2014) (1)
Impact of setanaxib on quality of life outcomes in primary biliary cholangitis in a phase 2 randomized controlled trial (2023) (1)
Sa1579 Durable Response in the Markers of Cholestasis through 18 Months of Open-Label Long Term Safety Extension Study of Obeticholic Acid in Primary Biliary Cirrhosis (2016) (1)
Incidence and Impact of Decompensating Events in Primary Biliary Cirrhosis : Results of an International Follow Up Study of 3030 Patients (2015) (1)
Evolution of Kidney Function after Liver Transplantation for Adult Polycystic Liver Disease and Indications for Combined Liver and Kidney Transplantation (2010) (1)
Abstract No. 135: A randomized phase II study of transarterial chemoembolization with doxorubicin eluting super absorbent polymer microspheres in patients with unresectable hepatocellular carcinoma (2010) (1)
Improved survival after LTx‐associated acute GVHD with mAb therapy targeting IL2RAb and soluble TNFAb: Single‐center experience and systematic review (2018) (1)
Outcome of patients with hepatocellular carcinoma listed for liver transplantation before and after the MELD-based allocation system within Eurotransplant. A BElgian multicentre retrospective study. (2011) (1)
LIVER TRANSPLANTATION FROM DONATION AFTER CARDIOCIRCULATORY DEATH (DCD) DONORS: BELGIAN EXPERIENCE 2003-2009 (2011) (1)
P0445 : Obeticholic acid, an FXR agonist, reduces hepatic fibrosis in a rat model of toxic cirrhosis (2015) (1)
Association between severe ischemia reperfusion injury and patient survival after liver transplantation (2013) (1)
The effect of universal infant vaccination on the prevalence of hepatitis B immunity in adult solid organ transplant candidates (2020) (1)
113 KERATIN19: A KEY ROLE PLAYER IN THE INVASION OF HUMAN HEPATOCELLULAR CARCINOMAS WITH PROGENITOR CELL FEATURES (2012) (1)
Everolimus in De Novo Liver Transplant Recipients To Either Minimize or Eliminate Tacrolimus - Study Design and Update (2010) (1)
Intestinal transplantation: a single-center experience (2006) (1)
Influence of different laboratory methods on MELD calculation in the Belgian liver transplant centres (2007) (1)
FRI-046-Raising awareness and messaging risk in patients with primary biliary cholangitis: The rapid Global PBC Screening Test (2019) (1)
Aplastic anemia after transplantation for non‐A, non‐B, non‐C fulminat hepatic failure: case report and review of the literature (2002) (1)
Long-Term Efficacy and Safety of Obeticholic Acid in Patients With Primary Biliary Cholangitis: A Demographic Subgroup Analysis of 5-Year Results From the POISE Trial. (2020) (1)
Acute Liver Failure : Abdominal organ transplant. Present and future (1997) (1)
Carbohydrate Deficient Transferrin in Patients with Cirrhosis: A Tale of Bridges. (2018) (1)
LBP-36-Inhibition of glutamine synthetase in monocytes from patients with Acute-on-Chronic Liver Failure resuscitates their antibacterial and inflammatory capacity (2019) (1)
Long-term, Prolonged-release Tacrolimus-based Immunosuppression in De Novo Liver Transplant Recipients: 5-year Prospective Follow-up of Patients in the DIAMOND Study (2021) (1)
Relevance of detecting additional small HCC lesions prior to liver transplantation (2003) (1)
The effect of spironolactone on variceal pressure in man and on portal pressure in the cirrhotic rat (1996) (1)
Low doses of spironolactone reduce portal vein pressure without affecting plasma volume in the rat (1996) (1)
Evolution of Renal Function with Early Everolimus-Facilitated Reduction or Elimination of Tacrolimus in 719 De Novo Liver Transplant Recipients: 12 Month Data of the H2304 Study (2012) (1)
Imaging techniques and Haemodynamic Measurements in Portal Hypertension (1996) (1)
[Transjugular intrahepatic portosystemic shunt in the treatment of refractory ascites in 21 patients]. (1996) (1)
CHOLESTASIS IN ACUTE LIVER REJECTION IS CHARACTERIZED BY INTRAHEPATIC CHOLESTASIS AND ADAPTIVE CHANGES IN BILE SALT TRANSPORTER EXPRESSION (2008) (1)
Clinical aspects of incomplete septal cirrhosis (1990) (1)
Incomplete septal cirrhosis (ICS),a syndrome intermediate between cirrhosis and obliterative portal venopathy (1991) (1)
Combined Liver-Thoracic Transplantation: Single-Center Experience Within the European Perspective (2015) (1)
Addition of epoprostenol (Epo) into the pressurized UW reduces the incidence of biliary stricture (BS) after liver transplantation (LTX) (2001) (1)
Multicenter, randomized trial of conversion to everolimus with calcineurin inhibitor minimization or discontinuation in liver transplant patients with renal impairment (2007) (1)
Everolimus With Reduced Tacrolimus Preserves Long-Term Renal Function in Liver Transplant Recipients: 36 and 48 Months Results From The H2304E1 Study.: Abstract# 2187 (2014) (1)
In Toxic Cirrhotic Rats, the FXR Agonist Obeticholic Acid Reduces Liver Fibrosis Indirectly via an Anti-Inflammatory Effect in Liver Sinusoidal Endothelial Cells and Kupffer Cells (2016) (1)
Acute liver failure: a European perspective (2010) (1)
Recanalization of portal axis after cavoportal hemitransposition in a liver transplant recipient with complete splanchnic thrombosis (2021) (1)
Prevalence of subclinical histological lesions and tolerance biomarkers in long-term adult liver transplant recipients considered for immunosuppression withdrawal (2018) (1)
Cell-of-origin based intrahepatic cholangiocarcinoma classification corresponds to Kras mutation status as well as cetuximab efficacy (2013) (1)
Everolimus Is Effective and Safe in Maintenance Liver Transplant Patients: Results of a Multicenter Randomized Conversion Study (2009) (1)
261 LONG-TERM SORAFENIB EXPOSURE IN HEPATOCELLULAR CANCER CELL LINES: RESISTANCE, RISK OF REBOUND GROWTH AND EPITHELIAL TO MESENCHYMAL TRANSITION (2011) (1)
Multicenter Belgian experience of sofosbuvir (medical need program) in very difficult-to-treat HCV patients: safety and efficacy results. (2015) (1)
A18 Random amplification with next-generation sequencing to cover HIV and HCV full-length genomes (2017) (1)
Erratum to “Human pluripotent stem cell-derived hepatocytes support complete replication of hepatitis C virus” [J Hepatol 2012;57:246–251] (2013) (1)
Multicenter Belgian experience of sofosbuvir medical need program in pre-and post-liver transplantation patients: safety and efficacy results. (2016) (1)
Molecular Adsorbent Recycling system (MARS) for acute on chronic alcoholic hepatitis: a case report (2001) (1)
Beta-3-adrenoceptors: a putative therapeutic target in liver cirrhosis of humans and animals (2008) (1)
Factors Predicting Survival In Patients With `Non-High-Risk' Acute Variceal Bleeding Receiving Nsbb And/Or Ebl To Prevent Re-Bleeding (2019) (1)
Preventing Rebleeding in 2010 (2010) (1)
Everolimus-Facilitated reduction of Tacrolimus provides comparble efficacy and superior renal function versus standard tacrolimus in de novo liver transplant recipients: 24-month results of a randomized trial (2012) (1)
Calcineurin inhibitor withdrawal in the presence of everolimus is feasible in maintenance liver transplant recipients (2008) (1)
Everolimus facilitates calcineurin inhibitor withdrawal in maintenance liver transplant patients with renal impairment. (2008) (1)
1047 KERATIN 19: A KEY ROLE PLAYER IN THE INVASION OF HUMAN HEPATOCELLULAR CARCINOMAS (2013) (1)
The H2304E1 Study: Efficacy and Safety of Everolimus With Reduced Tacrolimus Versus Standard Tacrolimus in De Novo Liver Transplant Recipients at 36 Months. (2014) (1)
Effect of terlipressin on portal pressure and on renal function in cirrhotic rats (1996) (1)
Durability of sustained virological response to glecaprevir/pibrentasvir and resistance development: A long‐term follow‐up study (2022) (1)
How to Deal With a Nonextractable Transjugular Intrahepatic Portosystemic Shunt Complicating Liver Transplantation (2018) (1)
Patients with a History of Bariatric Surgery Are 8 Years Younger at Presentation with Severe Alcoholic Hepatitis (2022) (1)
Pretransplant psychosocial and behavioral characteristics of heart, lung and liver transplant candidates: a comparative study (2005) (1)
26 EVEROLIMUS-BASED IMMUNOSUPPRESSION PROVIDES SUPERIOR RENAL FUNCTION AND COMPARABLE EFFICACY VERSUS STANDARD TACROLIMUS IN DE NOVO LIVER TRANSPLANT RECIPIENTS: 24-MONTH RESULTS OF A RANDOMISED CONTROLLED TRIAL (2013) (1)
POISE: A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis. The New England Journal of Medicine 2016, 375, 631-643 (2016) (1)
Liver or Kidney Transplantation After SARS-CoV-2 Infection: Prevalence, Short-term Outcome, and Kinetics of Serum IgG Antibodies (2021) (1)
The level of variceal pressure is a major predictor for variceal hemorrhage both in patients with cirrhosis as in patients with non-cirrhotic portal hypertension (1998) (1)
1402 EVEROLIMUS WITH EARLY REDUCTION OR ELIMINATION OF TACROLIMUS: 12 MONTH RESULTS OF A RANDOMIZED, CONTROLLED STUDY IN 719DE NOVO LIVER TRANSPLANT RECIPIENTS (2012) (1)
Predictive value of liver cell dysplasia in needle liver biopsies for subsequent hepatocellular carcinoma in viral-induced chronic hepatitis and cirrhosis (1999) (1)
P1180 : Identification of pbc patients in need of additional therapy during the course of UDCA treatment -an international multicenter study (2015) (1)
PS-022-Optimal timing of endoscopy is associated with lower 42-day mortality in variceal bleeding (2019) (1)
77 EMBOLIZATION OF LARGE SPONTANEOUS PORTOSYSTEMIC SHUNTS FOR REFRACTORY HEPATIC ENCEPHALOPATHY: A EUROPEAN MULTI-CENTER SURVEY ON SAFETY & EFFICACY (2013) (1)
Wound healing events and arterial complications with everolimus versus tacrolimus based regimens in de novo liver transplant recipients. O-22 (2012) (1)
Liver transplantation (LTx). for polycystic liver disease (PLD) (1999) (0)
University of Birmingham norUrsodeoxycholic acid improves cholestasis in primary sclerosing cholangitis (2017) (0)
Primary space occupying lesions of the non-cirrhotic liver: the point of view of the hepatologist (2001) (0)
Biliary strictures after liver transplantation: risk factors and prevention by donor epoprostenol treatment (2008) (0)
Durable response in the markers of cholestasis through 18 months of open-label extension with obeticholic acid in primary biliary cholangitis (2016) (0)
500 liver transplantations in a 10 year-period: progresses & remaining problems (2008) (0)
Hedgehog Pathway Targeted by Vitamin E Therapy in NASH Defining Optimal Laboratory Response Criteria in UDCA Treated Primary Biliary Cirrhosis. Results of an International Multicenter Long-term Follow-up Study (2013) (0)
Su1357: PATIENTS WITH PRIMARY BILIARY CHOLANGITIS TREATED WITH LONG-TERM OBETICHOLIC ACID IN A TRIAL-SETTING DEMONSTRATE BETTER EVENT-FREE SURVIVAL OUTCOMES THAN EXTERNAL CONTROLS FROM THE GLOBAL PBC AND UK-PBC STUDY GROUPS (2022) (0)
The value of minimally invasive surgery for the treatment of hepatocellular carcinoma (2012) (0)
Vaccination for HBV and Liver transplantation: what's new? (2016) (0)
Post-TIPS Hepatic Encephalopathy (2022) (0)
Combined liver/lung transplant for a copd patient with tuberculostatics-induced acute liver failure (2014) (0)
Efficacy of telaprevir-based therapy in stable liver transplant patients with chronic genotype 1 hepatitis C. (2016) (0)
Screening and Linkage to Care for Hepatitis C Viral Infection in the General Population in Belgium (2018) (0)
The Belgian experience with triple therapy with boceprevir and telaprevir in genotype 1 infected patients who inject drugs † Running title : Treatment of genotype 1 HCV infection in persons who inject drugs (2015) (0)
53 year-old female admitted with first episode of acute encephalopathy without a precipitant identified. 58 year-old male with recurrent post TIPS encephalopathy. Lactulose or antibiotics? When to close TIPS ( or large splenorenal shunt?)? (2011) (0)
858 ADP-DEGRADING ENZYMES INHIBIT PLATELET ACTIVATION IN BILE-DUCT LIGATED RATS (2010) (0)
University of Birmingham Practical Recommendations for Long-term Management of Modifiable Risks in Kidney and Liver Transplant Recipients (2017) (0)
Posttransplant lymphoproliferative disorder (ptld): characteristics and outcome in a belgian university hospital (2011) (0)
Diaphragmatic muscle fiber type IIb/IIx dimensions are reduced in rats with biliary cirrhosis (1996) (0)
Full-genome next-generation sequencing of hepatitis C virus to assess the accuracy of genotyping by the commercial assay LiPA and the prevalence of resistance-associated substitutions in a Belgian cohort. (2022) (0)
Detoxifying capacity and kinetics of the Prometheus system: Contribution of the different filters inbuilt (2005) (0)
79 THE OUTCOME OF SHUNT REDUCTION AFTER TIPS BY THE PARALLEL TECHNIQUE: A PROSPECTIVE STUDY (2013) (0)
152 A prospective open, single arm, pilot trial to assess the safety and efficacity of orlistat in obese liver transplant patients (2004) (0)
FRI-026-Long-term assessment of the effects of obeticholic acid in patients with primary biliary cholangitis on immune and inflammatory markers (2019) (0)
PRETRANSPLANT PREDICTORS OF MEDICATION NONADHERENCE AND CLINICAL OUTCOME AFTER TRANSPLANTATION: AN EVIDENCE BASE FOR PRETRANSPLANT PSYCHOSOCIAL AND BEHAVIORAL SCREENING. (2006) (0)
Biochemical patterns of alkaline phosphatase and bilirubin levels in relation to clinical outcomes in UDCA-treated PBC patients- an international study (2016) (0)
Detoxifying Capacity and Kinetics of the Molecular Adsorbent Recycling System: Contribution of the Different Filters Inbuilt (2003) (0)
Halofuginone treatment might aggravate fibrosis in a rat model of biliary cirrhosis (2003) (0)
Asymmetric dimethyl-L-arginine (ADMA): a possible cause of endothelial dysfunction in the bile-duct excised cirrhotic rat (2005) (0)
Ageing in Liver Transplantation: Does the Interaction of Donor and Recipient Age Matter? (2018) (0)
Reduction of portal pressure induced by subcutaneous somatostatine is not related to plasma glucagon suppression (1996) (0)
Consensus Statements: Management of the Acute Bleeding Episode (2016) (0)
The Authors' reply (2011) (0)
Characterization of a cell culture model for aggresive hepatocellular carcinoma induced by chronic hypoxia and pathway analysis: a central role for TGF-BETA aan ppar-alpha (2011) (0)
179 A PROSPECTIVE COHORT STUDY INVESTIGATING THE NATURAL HISTORY OF ACUTE-ON-CHRONIC LIVER FAILURE (2010) (0)
A comparison of different methods of ultrasonic assessment of transjugular intrahepatic portosystemic shunt dysfunction (1996) (0)
Treatment of decompensated viral hepatitis B induced liver cirrhosis with low dose interferon alpha (IFN) (1991) (0)
884 POLYCYSTIC LIVER DISEASE: A CLINICAL ANALYSIS OF 116 PATIENTS (2008) (0)
A wide interindividual difference between portal and variceal pressureexplains the lack of correlation between portal pressure andvariceal haemorrhage (2000) (0)
Predictors of IBD exacerbations after liver transplantation in patients with PSC and IBD (2014) (0)
Effectiveness and tolerability of pegIntron (R) in combination with Rebetol (R) in real life: the pegIntrust study (2006) (0)
P0959 : Dietary intervention completely reverses non-alcoholic steatohepatitis in obese and insulin resistant mice (2015) (0)
Thromboxane A2 affects the increased intrahepatic vascular tone of rats with cirrhotic portal hypertension, in part through interaction with nitric oxide production (2006) (0)
Younger age is associated with lower transplant-free survival relative to a general population in patients with Primary Biliary Cholangitis (2018) (0)
Higher self-reported non-adherence with co-medication compared to immunosuppressive drugs in heart, liver and lung transplant patients (2011) (0)
Need and timing of kidney in relation to liver transplantation in polycystic liver disease (2012) (0)
Outcome after liver transplantation using donation after cardiac death donors: a single-center experience (2011) (0)
The outcome of acute-on-chronic liver failure in the intensive care is similar to a propensity matched ICU population without liver disease (2018) (0)
Moving from early to moderate or advanced biochemical disease stage during follow-up is associated with an increasing risk of clinical events in primary biliary cholangitis patients (2017) (0)
Liver Transplant for Porto-sinusoidal Vascular Disease: Long-term Outcome (2021) (0)
Dietary intervention, but not losartan, completely reverses non-alcoholic steatohepatitis in obese and insulin resistant mice (2017) (0)
Young female patients with polycystic liver disease benefit the most from somatotastin analogue therapy: an individual patient data meta-analysis (2012) (0)
Gene transfer for endothelial nitric oxide synthase for the treatment of portal hypertension (2002) (0)
Geographical region and clinical outcomes of patients with primary biliary cholangitis from Western Europe (2022) (0)
Know your end-users: solid organ transplant patients’ use and acceptance of technology for self-management support (2015) (0)
The worldwide spread and evolution of HCV genotype 5a (2009) (0)
Intravenous substance use and the outcome of liver transplantation for chronic hepatitis C (2008) (0)
Mo1468 – Long Term Assessment of the Effects of Obeticholic Acid in Patients with Primary Biliary Cholangitis on Immune and Inflammatory Markers (2019) (0)
Evaluation of software to map NGS reads from heterogeneous HCV1b populations (2014) (0)
Risk factors to develop non-anastomotic strictures after liver transplantation (2013) (0)
Simultaneous liver and thoracic transplantation: indications and results at a single-center (2014) (0)
Expression of multidrug resistance-associated protein 1 in hepatocellular carcinoma is associated with aggressive tumor phenotype and can reflect progenitor cell origin (2007) (0)
Disturbed glucose homeostasis in vagotomized rats with taa-hepatitis: An explanation for post liver transplant diabetes (2007) (0)
Etiology of chronic pancreatitis: two-yr-single-centre experience in a tertiary hospital in Belgium (2013) (0)
The t1/2 value of 13C-octanoic acid excretion is not changed in cirrhotic patients (2001) (0)
EVEROLIMUS IS EFFECTIVE AND SAFE IN A SIX-MONTH, RANDOMIZED, MULTICENTER CONVERSION TRIAL IN MAINTENANCE LIVER TRANSPLANT RECIPIENTS: 281 (2008) (0)
FRI-424-Estrogen-containing oral contraceptives are associated with polycystic liver disease severity in pre-menopausal patients (2019) (0)
A history of bariatric surgery is independently associated with a younger age at onset of severe alcoholic hepatitis (2022) (0)
Diffuse splanchnic thrombosis and refractory ascites after liver transplantation: a new indication for peritoneo-venous shunts (2007) (0)
Embolization of large portosystemic shunts for refractory hepatic encephalopathy: a european survey (2013) (0)
Belgian experience with an extranet database for patients listed for liver transplantation (2000) (0)
Implications of hepatitis C virus subtype 1a migration patterns for virus genetic sequencing policies in Italy (2017) (0)
SARS‐CoV‐2 vaccine antibody response and breakthrough infections in transplant recipients (2023) (0)
Preserved platelet function but plasmatic inhibition of platelets in cholestatic liver disease (2008) (0)
Personalized subcutaneaous administration of hepatitis B surface antibodies without nucleo(t)ide analogues is highly effective and reduces cost for hepatitis B prophylaxus after liver transplantation (2017) (0)
Ductular bilirubinostasis is a diagnostic biomarker for acute-on-chronic liver failure: results from a well-defined cohort of patients with alcoholic steatohepatitis (2022) (0)
Relapse rates and clinical outcomes after nucleos(t)ide analogue therapy stop in a Belgian, predominantly caucasian cohort of chronic hepatitis B patients (2017) (0)
Splanchnic artery embolization safely facilitates exenteration-phase during multivisceral transplantation (2015) (0)
A comparative analysis of the HCV genotype 5a molecular epidemiology in Belgium and South Africa (2006) (0)
Allocation in liver transplantation : is the sickest-first principle justified? (2011) (0)
Alpha-interferon induces HBeAg− chronic active liver disease but improves long-term survival in HBeAg+ chronic active hepatitis patients (1998) (0)
eHuman subcutaneous and visceral fat inflammatory gene signatures accurately predict histological severity of non-alcoholic fatty liver disease (2014) (0)
Polycystic Liver Disease Patients with Underlying Diagnosis of Polycystic Kidney Disease are More Likely to Undergo Liver Transplantation than Patients with Isolated Polycystic Liver Disease (2016) (0)
1312 ABNORMAL PRIMARY CILIA IN CHOLANGIOCYTES CAUSE CHOLESTATIC LIVER DISEASE IN HNFlβ DELETION IN HUMANS (2011) (0)
Cover Image (2021) (0)
Gene Therapy to Reduce Portal Hypertension : Possible Bridge to Liver Transplantation (2000) (0)
Approach to the Management of Bleeding Esophageal Varices : Role of Somatostatin (1998) (0)
Results of intestinal transplantation using low-dose immunosuppression (2003) (0)
Combined liver kidney transplantation in the MELD era. Single center analysis (2013) (0)
CLINICAL ADVANCES IN LIVER, PANCREAS, AND BILIARY TRACT Lanreotide Reduces the Volume of Polycystic Liver: A Randomized, Double-Blind, Placebo-Controlled Trial (2009) (0)
Treatment of acute variceal bleeding: A review.Endoscopic diagnosis and treatment of gastrointestinal and hepatobiliary diseases (1998) (0)
POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDER (PTLD): FINAL ANALYSIS OF CHARACTERISTICS AND OUTCOME IN A BELGIAN UNIVERSITY HOSPITAL (2011) (0)
Risk factors to develop biliary non-anastomotic strictures, a single center experience (2014) (0)
The prevalence of Transfusion Transmitted Virus (TTV) infection in Belgian population: an epidemiological study for the clinical significance (2000) (0)
Discussion on medical treatment of portal hypertension (2004) (0)
Tolerogenic protocol with low immunosuppression for intestinal transplantation: 90% 10-year survival (2013) (0)
Occurrence and Clinicopathological Relevance of Prognostic Markers in Hepatocellular Carcinoma (2011) (0)
Case report: Acute intermittent porphyria, cured by liver transplantation? (2014) (0)
Model to predict the need for liver transplantation in polycystic liver disease based on objective criteria (2013) (0)
PTU-009 Long-term effects of obeticholic acid in patients with primary biliary cholangitis on inflammatory markers (2019) (0)
Malondialdehyde as a good marker of oxidative stress in liver diseases (1999) (0)
P-84: Mixed Physiological and Non-physiological Portal Inflow as an Alternative to Multivisceral Transplantation in a Patient with Diffuse Splanchnic Thrombosis (2021) (0)
One year experience of the Belgian Liver Intestine Comittee (BLIC) intranet database (2001) (0)
Transplantation of the small intestine: a one-year follow-up (2001) (0)
175 IMPACT OF TIGHT GLYCEMIC CONTROL IN PATIENTS WITH DECOMPENSATED CHRONIC LIVER DISEASE ADMITTED TO INTENSIVE CARE: RESULTS OF A SINGLE-CENTRE RANDOMIZED CONTROLLED TRIAL (2010) (0)
Presumed healthy donor organs with heterozygous alpha-1-antitrypsin Z allele mutation: implications for liver transplant recipients (2011) (0)
The impact of pulmonary arterial hypertension therapy in patients with portopulmonary hypertension: a single tertiary center cohort analysis (2018) (0)
Liver Cirrhosis and its complications-Acute liver failure-liver transplantation (2016) (0)
P0261 : A global risk gene score predicts early and late tumor recurrence after resection of hepatocellular carcinoma (2015) (0)
Pharmacokinetic Interactions between Simeprevir and Ledipasvir in Treatment-Naïve Hepatitis C Virus Genotype 1-Infected Patients without Cirrhosis Treated with a Simeprevir/Sofosbuvir/Ledipasvir Regimen (2016) (0)
Added value of monoclonal antibodies in treatment of acute graft versus host disease after liver transplantation: a single center experience in an international perspective (2017) (0)
O088 : High-throughput sequencing of the human hepatic progenitor cell niche reveals different signalling pathways depending on the underlying chronic liver disease (2015) (0)
1058 THE KRAS MUTATION REFLECTS THE DIFFERENT CHOLANGIOCYTES PHENO- AND GENOTYPE IN INTRAHEPATIC CHOLANGIOCARCINOMA (2012) (0)
HSCs: hepatic stellate cells MLCK: Ca /calmodulin-dependent myosin light chain kinase rMLC: regulatory light chain of myosin PKC: protein kinase C MLCP: myosin light chain phosphatase IHVR: intrahepatic vascular resistance (2006) (0)
Peroral cholangioscopy in biliopancreatic interventions: results of belgian single center cohort (2012) (0)
Cessation of nucleos(t)ide analogue therapy after HBEAG seroconversion is associated with a decreased chance of HBSAG loss in a Belgian, predominantly caucasion cohort of chronic hepatitis B patients (2017) (0)
218 MIR141 AND MIR200C REGULATE PROGENITOR CELL FEATURES IN HEPATOCELLULAR CARCINOMAS (2011) (0)
Early prognostic features in acute-on-chronic alcoholic liver failure: a detailed clinicopathological study (2008) (0)
Spontaneou S life-threatening hemobilia during a Cute liver failure Su CCeSSfully treated with tran Sarterial embolization (2014) (0)
Liver transplantation without steroids (1999) (0)
Terlipressin enhances free water clearance in CCl4 phenobarbital enhanced cirrhosis in the rat (1996) (0)
Clinical outcomes in polycystic liver disease comparing autosomal dominant polycystic liver disease with autosomal polycystic kidney disease: results of the PLD registry (2017) (0)
IN2 MODELING LONG-TERM MORTALITY AND MORBIDITY IMPACT WITH ENTECAVIR TREATMENT IN CHB PATIENTS IN BELGIUM (2008) (0)
Reversal of hepatorenal syndrome in 4 patients by peroral prostaglandin E 1 analogue and albumin (1989) (0)
Effectiveness of interferon alfa in caucasian patients with viral compensated cirrhosis (1997) (0)
Discontinuation of vitamin K in Budd-Chiari patients with a well managed underlying myeloproliferative disorder: lessons from a small case-series (2015) (0)
P051: HBV genotype fluctuation (shifting and reversion) after liver transplantation (2015) (0)
[Gastrointestinal hemorrhage. Which indications for endoscopic treatments?]. (2004) (0)
Oral Sessions Oral Session 37 : Non-renal DCD / ECD (2011) (0)
The value of non-invasive tools to diagnose HCC or pre-malignant dysplastic nodules in patients with advanced cirrhosis and a hepatic mass (2004) (0)
Liver transplantation (LTx): results, progresses and remaining problems. An analysis based on 500 LTx in a 10-year period (2008) (0)
Combination therapy of nitrates and spironolactone in the treatment of experimental portal hypertension (1995) (0)
Pilot study: Ethyl glucuronide (EtG) in hair and serum carbohydrate deficient transferrin (CDT) for the detection of heavy alcohol use in patients with and without liver disease (2013) (0)
Safety and ef fi cacy of different lanreotide doses in the treatment of polycystic liver disease : pooled analysis of individual patient data (2013) (0)
Prothrombin complex concentrate in the reduction of blood loss during orthotopic liver transplantation (2013) (0)
Understanding the pathogenetic mechanisms of acute renal failure (ARF) in non-fulminant hepatitis A virus (HAV) infection. (1997) (0)
Bacterial translocation during experimental cirrhosis coincidences with the infiltration of inflammatory monocytes in the gut (2018) (0)
Hepatocyte differentiation in cholangiocarcinoma, suggesting hepatic progenitor cell origin (2007) (0)
Association between ursodeoxycholic acid therapy and prolonged transplant-free survival among patients with primary biliary cholangitis a number needed to treat analysis (2016) (0)
The successful application of endoscopic ultrasound guided fine needle biopsy to establish pancreatic patient-derived tumor xenogafts (2016) (0)
[163] CORRELATION BETWEEN HEPATOCYTE AND HEPATIC PROGENITOR CELL REGENERATION AND MODEL FOR END STAGE LIVER DISEASE (MELD) SCORE IN ACUTE SEVERE LIVER IMPAIRMENT (2007) (0)
O104 : Predictive model for the need for liver transplantation in symptomatic polycystic liver disease (2015) (0)
MELD is not superior to King's College hospital criteria in adult patients with non-acetaminophen induced acute liver failure (2006) (0)
TIPSS placement in the digestive oncology setting (2007) (0)
Lanreotide reduces in a dose-dependent way liver volume in patients with polycystic liver disease (2013) (0)
Serum HCV-RNA, transaminases and HCV-antibodies in patients with chronic non-A, non-B hepatitis treated with interferon alpha-2B (IF) (1991) (0)
Early-tips should be performed in high-risk cirrhotic patients despite the presence of hepatic encephalopathy at admission (2020) (0)
Paritaprevir/Ritonavir, Ombitasvir and Dasabuvir with or without ribavirin archieves 98;6% sustained virologic response in belgian gti infected patients (2015) (0)
O085 : Lanreotide reduces liver volume yet accelerates muscle wasting and weight loss in symptomatic polycystic liver disease (2015) (0)
Relevance of understaging HCC by imaging prior to liver transplantation (2002) (0)
Su1667 Usefullness of the Single-Operator Cholangioscopy-System SPYGLASS in Biliopancreatic Diagnostic and Therapeutic Interventions: a Single-Center Cohort Study (2014) (0)
P1252 EVEROLIMUS HALTS DISEASE PROGRESSION IN A RODENT MODEL OF POLYCYSTIC LIVER DISEASE: RESULTS OF A LONGITUDINAL MRI-STUDY (2014) (0)
Extrahepatic manifestations of liver diseases (1991) (0)
Acute liver failure. (1997) (0)
Abnormal primary cilia in cholangiocytes associated with cholestatic liver disease in HNF1beta deletion in humans (2011) (0)
1289 CHOLESTASIS-ASSOCIATED PRURITUS TREATED WITH UVB PHOTOTHERAPY: REPORT OF 13 CASES (2011) (0)
Utility and prognostic value of diagnosing metabolic dysfunction-associated fatty liver disease in patients undergoing liver transplantation for alcohol-related liver disease (2022) (0)
Disease profile, selection criteria and outcome of patients referred to intestinal transplantation: a center experience (2005) (0)
Pre-emptive (early) transjugular intrahepatic porto-systemic shunt in the treatment of high-risk acute variceal bleeding. An individual patient data meta-analysis (2020) (0)
O-013A global risk gene score predicts early and late tumor recurrence after resection of hepatocellular carcinoma (2015) (0)
Portopulmonary hypertension : has the prognosis improved? (2012) (0)
Association of infection with a specific hepatitis G virus strain with fulminant hepatitis (1998) (0)
Predictive value of liver cell dysplasia in needle liver biopsies for subsequent hepatocelluar carcinoma in viral-induced (2000) (0)
incidence and Impact of Decompensating Events in Primary Biliary Cirrhosis - Results of an International Follow Up Study of 3030 Patients. : 73 (2015) (0)
P0275 : PDGFRA-mediated laminin B1 deposition induces invasion in human hepatocellular carcinoma (2015) (0)
COMBINED LIVER AND KIDNEY TRANSPLANTATION: LISTING CRITERIA AND RESULTS (2013) (0)
A gene signature derived from sorafenib resistant liver cancer cells identifies HCC patients with poor prognosis (2014) (0)
Efficacy and Safety of Everolimus with Early Reduction or Elimination of Tacrolimus in 719 d e Novo Liver Transplant Recipients - Results at 12 Months: 1556 (2012) (0)
Multicenter Belgian survey on liver transplantation for hepatocellular failure after bilio-pancreatic diversion (Scopinaro operation) for weight loss (2010) (0)
SAT-079-Respiratory infection in patients with cirrhosis and acute variceal bleeding on antibiotic prophylaxis: A multicenter observational study of 2138 patients (2019) (0)
Monocytes exhibit an immune and metabolic reprogramming during acute-on-chronic-liver-failure (2017) (0)
Su1351: TREATMENT WITH SELADELPAR IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS (PBC) AND PRIOR EXPERIENCE WITH OBETICHOLIC ACID OR FIBRATES (2022) (0)
PostersPoster Session – Friday, April 20, 201202c. Cirrhosis and ITS Complications: Bleeding661 USE OF EARLY-TIPS FOR HIGH-RISK VARICEAL BLEEDING. RESULTS OF A POST-RCT SURVEILLANCE STUDY (2012) (0)
Further Evidence That Lanreotide Reduces Liver Growth in Patients With Polycystic Liver Disease, But Not the End of the Story (2019) (0)
Utility and prognostic value of diagnosing MAFLD in patients undergoing liver transplantation for alcohol-related liver disease. (2023) (0)
Ursodeoxycholic acid in Belgium: the prevalence of allegedly stable biliary diseases is not obvious to determine from consumption data (2004) (0)
Progress in the treatment of acute variceal haemorrhage: The Leuven experience with TIPS. Emergencies in gastroenterology and hepatology (1996) (0)
Influence of intraoperative high-dose steroids on ischemia/reperfusion injury (IRI) after liver transplantation (2001) (0)
Somatostatin for acute oesophageal variceal bleeding - Reply (1998) (0)
662 OUTCOME OF PATIENTS WITH HEPATOCELLULAR CARCINOMA LISTED FOR LIVER TRANSPLANTATION BEFORE AND AFTER THE MELD-BASED ALLOCATION SYSTEM WITHIN EUROTRANSPLANT A BELGIAN MULTICENTRE RETROSPECTIVE STUDY (2011) (0)
Liver failure requiring liver transplantation (LTx) following weight-reduction surgery for morbid obesity (2005) (0)
Outcome after liver transplantation using dcd donors: a single-center experience (2012) (0)
A dose-response relationship in the association between ursodeoxycholic acid treatment and prolonged transplant-free survival in primary biliary cholangitis (2018) (0)
Liver transplantation (LTx) for polycystic liver disease (PLD) (1999) (0)
Survival after liver transplantation (LTx) versus combined liver plus thoracic or abdominal organs (2007) (0)
In CCl4 cirrhosis but not in prehepatic portal hypertension or in biliary cirrhosis is a reduced expression of ceNOS found in rat liver (2000) (0)
Optimising trial design in late-stage primary biliary cholangitis : evaluating options for composite clinical endpoint studies (2019) (0)
A strange case of necrotizing hepatitis leading to acute liver failure (2010) (0)
Spontaneous life-threatening hemobilia during acute liver failure successfully treated with transarterial embolization. (2014) (0)
A prospective multicenter registry of hepatitis C virus genotype 4 from Belgium (2010) (0)
Incidental portopulmonary hypertension discovered after the start of liver transplantation: "to go ahead or to let go ..." (2011) (0)
A cryptic case of encephalopathy (2011) (0)
153 The predictive value of non-invasive diagnostic tools to detect HCC or pre-malignant dysplastic nodules in patients with advanced cirrhosis and a hepatic mass (2004) (0)
Early experience with the molecular absorbent recycling system (MARS) as a rescue treatment for liver failure (2001) (0)
Impact of HCV1a migration patterns on the public health policy regarding genotyping of the Q80K resistanceassociated variant in Italy (2016) (0)
Completely steroid-free immunosuppression after liver transplantation (2000) (0)
Transcatheter arterial embolization with doxorubicin eluting SAP microspheres in treatment of HCC (2013) (0)
Roux-en-y gastric bypass attenuates hepatic mitochondrial dysfunction in mice with NASH (2014) (0)
P1186 TREATMENT-NAIVE STABLE LIVER TRANSPLANT PATIENTS WITH GENOTYPE-1 HCV INFECTION: PHARMACOKINETIC RESULTS OF ADJUSTED DOSING WITH TACROLIMUS OR CYCLOSPORINE IN THE TELAPREVIR REPLACE STUDY (2014) (0)
Interstitial Yag laser hyperthermia is more suitable for intrahepatic tumor destruction than alcoholisation (1989) (0)
Hepatitis C virus genotype and prognosis of compensated cirrhosis type C (1999) (0)
Lessons in Developing a Full-Genome Next-Generation Sequencing Pipeline for Molecular Epidemiology of Hcv (2022) (0)
Satavaptan, a v2-receptor antagonist and aquaretic drug, improves portal hypertension in non-ascitic thiocetamide-induced cirrhotic rats (2009) (0)
It's all about the veins... a rare case of portal biliopathy leading to recurrent biliary obstruction, non-cirrhotic portal hypertension, liver failure and need for transplantation (2012) (0)
521 THE VASOPRESSIN-2-RECEPTOR ANTAGONIST SATAVAPTAN IMPROVES PORTAL HYPERTENSION IN THE NON-ASCITIC THIOACETAMIDE CIRRHOTIC RAT WITHIN A NARROW SAFE AND EFFECTIVE DOSE-RANGE (2010) (0)
569 Quantitation of HCV positive- and negative strand RNA in liver tissue by strand-specific Taqman real-time PCR assays (2003) (0)
Satavaptan, a v2-receptor antagonist and aquareticum, improves portal hypertension in cirrhotic rats without ascites (2008) (0)
120 A 7 GENE SET ASSOCIATED WITH CHRONIC HYPOXIA OF UNIVERSAL PROGNOSTIC IMPORTANCE IN HEPATOCELLULAR CARCINOMA (2010) (0)
White book hepatitis (1992) (0)
Efficacy and safety of everolimus in de novo liver transplant recipients - 12 month results of a randomized multicenter study. O-80 (2012) (0)
A multicentric study to estimate mortality and graft loss risk after liver transplantation (LT) in patients with recurrent primary biliary cholangitis (PBC) (2022) (0)
The effect of long-term treatment with spironolactone on variceal pressure in patients with portal hypertension (1995) (0)
Reply (2014) (0)
Prevalence of noncompliance with the immunosuppressive therapy after orthotopic liver transplantation (1999) (0)
Hepatitis C prevalence in incarcerated settings between 2013–2021: a systematic review and meta-analysis (2022) (0)
229 SUCCESSFUL CONVERSION FROM MYCOPHENOLATE MOFETIL TO ENTERIC-COATED MYCOPHENOLATE SODIUM (MYFORTIC®) IN LIVER TRANSPLANT PATIENTS WITH GASTROINTESTINAL SIDE EFFECTS (2008) (0)
SOMATOSTATIN FOR ACUTE OESOPHAGEAL VARICEAL BLEEDING. AUTHORS' REPLY (1998) (0)
Portopulmonary Hypertension: From Diagnosis to Outcome (2012) (0)
Long-term obeticholic acid (OCA) for primary biliary cholangitis (PBC) in a clinical trial improved event free survival (death, liver transplant and hepatic decompensation) compared to external controls from the GLOBAL PBC real-world database (2022) (0)
Reply: To PMID 23401201. (2014) (0)
Mo1454 - Durable Response in the Markers of Cholestasis Through 36 Months of Open-Label Extension Study of Obeticholic Acid in Primary Biliary Cholangitis (2018) (0)
Validation of a semi-automatic method to measure total liver volumes in polycystic liver disease on computed tomography — high speed and accuracy (2023) (0)
The good, the bad and ... the imposter: irrevesibly tricked by a blind trust in technology (2010) (0)
Increase in age at diagnosis of primary biliary cholangitis over the last 40 years (2017) (0)
196 COPEPTIN AS BIOMARKER OF SYSTEMIC HEMODYNAMIC DERANGEMENTS IN TAA CIRRHOTIC RATS (2013) (0)
PGI14 Resource Use and Cost of Hepatitis C Related Care in Belgium (2011) (0)
Uncovering monocyte transcription, functional and metabolic signatures in recovery and non-recovery ACLF patients (2022) (0)
Liver Transplantation Using Grafts from Donors Older Than Seventy and Eighty Years Old (2010) (0)
Pathophysiology of acute on chronic liver failure: the good, the bad and the ugly (2015) (0)
Seladelpar efficacy and safety at 3 months in patients with primary biliary cholangitis: ENHANCE, a phase 3, randomized, placebo-controlled study (2023) (0)
Safety and efficacy of sofosbuvir (medical need program) in very difficult-to-treat HCV patients: the Belgian experience. (2015) (0)
The impact of geographical region on outcomes of patients with primary biliary cholangitis from western Europe (2020) (0)
Large-scale, multi-centric prospective validation of the polycystic liver disease complaint-specific assessment (POLCA) (2022) (0)
Hepatitis C virus genotype and risk of hepatocellular carcinoma in compensated cirrhosis type C (1998) (0)
The relationship between the distribution of susheptatic vein involvement and the underlying pro-thrombotic risk factor in patients with budd-chiari syndrome (2015) (0)
Liver and brain: is there a link? (2010) (0)
Quality of life outcomes in patients with primary biliary cholangitis treated with setanaxib: post-hoc results from a phase 2 randomised, placebo-controlled trial (2022) (0)
ecNOS gene transfer enhances no production and NOS protein expression in the CCl4 cirrhotic rat liver resulting in prolonged decrease of portal pressure (2000) (0)
Progression of fibrosis in HCV+ liver transplant recipients treated with cyclosporine or tacrolimus (2013) (0)
Survival and prognostic indicators in cryptogenic compensated cirrhosis (1995) (0)
The prevalence of cardiac induced liver disease in patients with a chronic right heart disorder (2017) (0)
Ab initio completely steroid-free immunosuppression during and after liver transplantation: long-term 3 year follow-up report (2003) (0)
Long-term outcome after TIPS procedure (1995) (0)
5.60 Chronic Lymphocytic Leukemia: Contra-Indication for Transplantation? (2011) (0)
T06.01.3 DURABLE RESPONSE IN THE MARKERS OF CHOLESTASIS THROUGH 5 YEARS OF OPEN-LABEL EXTENSION STUDY OF OBETICHOLIC ACID IN PRIMARY BILIARY CHOLANGITIS (2020) (0)
The efficacy and clinical outcome of transjugular intrahepatic portosystemic shunts in the management of ectopic variceal bleeding: a multicenter retrospective study (2018) (0)
IMPROVED OUTCOME OF LIVER TRANSPLANTATION FOR HEPATITIS C IN A MORE RECENT ERA. (2004) (0)
Commentary: Hepatitis: A way to make organ donation go viral? (2019) (0)
Mimicking liver development, functional hepatocyte-like cells can be generated from embryonic stem cells but also from cells with primitive endoderm phenotype (2010) (0)
Indications and results of combined liver and thoracic transplantation (2014) (0)
Everolimus-Facilitated Reduction of Tacrolimus Maintains Comparable Efficacy and Better Renal Function Versus Standard Tacrolimus in De Novo Liver Transplant Recipients (2013) (0)
178 A PROSPECTIVE STUDY COMPARING THE DIFFERENT INDIRECT METHODS TO MEASURE PORTAL PRESSURE (2011) (0)
Farnesoid X receptor activation limits intestinal ischemia reperfusion injury and increases survival (2016) (0)
Chronic lymphocytic leukemia: contra-indication for transplantation? (2011) (0)
TIPS for ascites: Barewall vs covered stents? (2011) (0)
Human Colestatic and Autoimmune Liver Diseases (2016) (0)
Valdidation of immunohistochemical staining with the monoclonal antibody 17H10 in liver biopsies for the diagnosis of chronic hepatitis C (2001) (0)
Serum gamma-glutamyltransferase is a prognostic biomarker in primary biliary cholangitis and improves risk stratification based on the alkaline phosphatase (2020) (0)
In Memoriam: Jan De Groote (1925–2018) (2018) (0)
O-154 MONITORING OF PERIPHERAL BLOOD NATURAL KILLER CELLS TO IDENTIFY HEART TRANSPLANT RECIPIENTS AT RISK OF INFECTION (2011) (0)
Efficacy and Safety of Everolimus Based Immunosuppression in HCV Positive De Novo Liver Transplant Recipients (2012) (0)
Combined bile duct excision-formalin injection: a model to study progressive (vanishing) bile duct disease (2001) (0)
TIPS for ascites:what evidence do we have? (2011) (0)
682 APPARENT DIFFUSION COEFFICIENT DETERMINED TARGET RESPONSE AT DIFFUSION-WEIGHTED MRI IS AN INDEPENDENT PREDICTOR OF OUTCOME IN HEPATOCELLULAR CANCER PATIENTS TREATED WITH TRANSARTERIAL CHEMOEMBOLIZATION (2013) (0)
P79 SIDE POPULATION ANALYSIS IDENTIFIES A ROLE FOR LAMININ IN MODULATING THE HUMAN HEPATIC CANCER STEM CELL NICHE (2014) (0)
Robust hepatocyte differentiation protocol for rat and mouse multipotent adult progenitor cells, human and mouse embryonic stem cells and mouse induced pluripotent stem cells (2009) (0)
Changes in elastography is a predictor of clinical outcome in patients with compensated advanced liver disease (2012) (0)
Bleeding from anorectal varices, a rare but frequently lethal complication of liver cirrhosis (1998) (0)
A More Intensive Regimen of Albumin Dyalisis Improves Survival in Patients with Acute on Chronic Liver Failure. Results from an Individual-Patient Data Meta-Analysis (2016) (0)
Simultaneous liver and thoracic transplantation is a life-saving procedure (2014) (0)
Percutaneous shunt reduction for the management of TIPS-induced acute liver decompensation: A follow-up study. (2016) (0)
Rapid, persistent hepatitis B viral DNA suppression predicts nucleos(t)ide, analogue induced HBeAG seroconversion in a belgian, predominantly caucasian cohort of chronic hepatitis B patients (2017) (0)
PS-023-Factors predicting survival in patients with high-risk acute variceal bleeding treated with pre-emptive (Early)-TIPS (2019) (0)
Lung machine preservation allows liver prior to lung transplant in a COPD patient with tuberculostatics-induced liver failure (2014) (0)
Pre-operative arterial embolization facilitates multivisceral transplantation (2015) (0)
Stratification of hepatocellular carcinoma risk using the GLOBE score in patients with primary biliary cholangitis– the Global PBC Study Group (2018) (0)
Octreotide induces a negative water balance in healthy and cirrhotic rats during a salt load without changing arterial or portal pressure (1995) (0)
Efficacy and safety of everolimus in maintenance liver transplant recipients: results of a multi-center, randomized, open-label conversion study (2008) (0)
The effect of different bolus injections of somatostatin on the oesophageal intravariceal pressure in cirrhotic patients (1991) (0)
Pretransplant predictors of medication nonadherence and clinical outcome after transplantation: am evidence base for pretransplant and behavioural screening (2006) (0)
Genetic polymorphisms in primary sclerosing cholangitis: a candidate gene study (2005) (0)
Sarcopenia in symptomatic PCLD patients: a more objective parameter for liver allocation? (2013) (0)
Session 1 ‒ Definition of Key Events: Lets's Try Again (2008) (0)
Hepatitis C reinfection in former and active injecting drug users in Belgium (2021) (0)
Utility of gas chromatography/mass spectrometry to detect breath biomarkers in patients with liver impairment: preliminary data? (2011) (0)
Development and validation of a novel risk score predicting long-term survival in autoimmune hepatitis (2020) (0)
77% patient survival after intestinal transplantation: a 10 year experience (2011) (0)
Hair ethyl glucuronide as a marker of alcohol use in patients with alcoholic cirrhosis: Ready for clinical implementation? (2016) (0)
THU-219-Long-term outcome in Caucasian patients with hepatitis B e antigen-negative chronic infection: An observational cohort study (2019) (0)
Efficacy of everolimus in 719 liver transplant recipients: a randomized, controlled study (2012) (0)
University of Birmingham Levels of alkaline phosphatase and bilirubin are surrogate end points of outcomes of patients with primary biliary cirrhosis (2014) (0)
P1147 : Validation of an alkaline phosphatase and bilirubin response criterion as biomarker for transplant-free survival in primary biliary cirrhosis in the world's two largest cohorts (2015) (0)
Acute mental alterations in a liver transplant patient: recurrence of hepatic encephalopathy (2012) (0)
Cholestasis and diabetes: always blame it on glycaemia? (2012) (0)
Survival after liver transplantation versus combined liver plus other thoracic or abdominal organs (2007) (0)
BETA-3-ADRENOCEPTOR-AGONISTS LEAD TO INTRAHEPATIC VASODILATION VIA GS/CAMP STIMULATION AND DECREASED RHO-KINASE ACTIVITY IN LIVER CIRRHOSIS (2009) (0)
Need and timing of kidney transplantation in relation to liver transplantation in polycystic liver disease (2011) (0)
Everolimus-Facilitated Reduction of Tacrolimus in De Novo Liver Transplant Recipients Achieves Comparable Overall Efficacy with Fewer Biopsy-Proven Acute Rejections Versus Standard Tacrolimus: 24-Month Results of a Randomized Trial (2013) (0)
Mortality and morbidity in cryptogenic (type C) compensated cirrhosis: a multicenter study (1995) (0)
Performance of the AFP model in predicting prognosis after liver transplantation in patients with hepatocellular carcinoma: a single center retrospective validatiion (2015) (0)
941 ALKALINE PHOSPHATASE VALUES ARE A SURROGATE MARKER IN PREDICTION OF TRANSPLANT FREE SURVIVAL IN PATIENTS WITH PRIMARY BILIARY CIRRHOSIS – AN INTERNATIONAL, COLLABORATIVE ANALYSIS (2013) (0)
A rare presentation of an apparently non-liver related problem:who's done it? (2011) (0)
Tacrolimus drug exposure level in the first year after liver transplantation is an independant risk factor for de novo malignancy in patients transplanted for alcohol-related liver disease (2022) (0)
The Impact of Liver Transplantation after Surgical Treatment of Hepatocellular Carcinoma (2014) (0)
Effect of low- and high-grade portal vein thrombosis on outcome after liver transplantation: single center experience (2015) (0)
Distal splenorenal (warren) shunt in patients suffering from portal vein thrombosis: a single center experience and analysis of long-term outcome (2015) (0)
75 KERATIN 19 EXPRESSION IN HEPATOCELLULAR CARCINOMA IS CORRELATED WITH POSTOPERATIVE TUMOUR RECURRENCE AND METASTASIS MARKERS (2010) (0)
P882 COMBINED OR NOT COMBINED LIVER/KIDNEY TRANSPLANTATION FOR SYMPTOMATIC POLYCYSTIC LIVER DISEASE: SINGLE CENTER LONG-TERM OUTCOME EXPERIENCE (2014) (0)
Sumatriptan reduces variceal pressure without affecting portal pressure (1999) (0)
Octreotide stimulates the free water clearance in healthy and cirrhotic rats (1996) (0)
Integrated efficacy and safety analysis of GT1-6 treatment-naive, non-cirrhotic and compensated cirrhotic patients who received 8 weeks of glecaprevir/pibrentasvir (2020) (0)
First report on combined lung-liver transplantation in patients with progressive hepatic and pulmonary epithelioid hemangioendothelioma (2015) (0)
Activated intestinal macrophag release NO and IL-6 that may disrupt intestinal barrier function (2013) (0)
Economic Impact of European Liver and Intestine Transplantation Association (ELITA) Recommendations for Hepatitis B Prophylaxis After Liver Transplantation (2023) (0)
Meld score predicts the risk of death in patients with non-acetaminophen-induced acute liver failure (2005) (0)
Patients with alcoholic liver disease often have preserved peripheral antioxidant levels despite ongoing oxidative liver damage (2001) (0)
Physical fitness before and after liver transplantation: a longitudinal study (2013) (0)
An observational trial assessing the efficacy of pegintron and rebetol according to liver fibrosis in naive genotype 1/4/5/6 chronic hepatitis c patients (2011) (0)
The value of immunohistochemical staining with a monoclonal antibody against HCV-E2 to study HCV reinfection and the effect of treatment post-LTx (2002) (0)
Histamine dihydrochloride (Maxamine®) and interferon-a-2b (IFN-a-2b) as a potential new combination therapy for chronic hepatitis C (HCV): 12- week results of a phase II trial (2000) (0)
Diagnostic Items for Renal and Hepatic Cyst Infection – A Delphi Survey (2015) (0)
Terlipressin enhances free water clearance in experimental cirrhosis in the rat (1995) (0)
Successful combined lung-liver transplantation in patients with progressive hepatic epithelioid hemangioendothelioma and pulmonary metastases (2015) (0)
Hair ethyl glucuronide is a highly accurate and objective biomarker of continued alcohol, use in patients with alcoholic cirrhosis (2017) (0)
Formalin injection into the bile duct together with bile duct excision induced a stable model to study portal hypertension in biliary cirrhosis (2000) (0)
899 MICRORNA EXPRESSION OF KERATIN 19 POSITIVE HEPATOCELLULAR CARCINOMAS INDICATES STRONG TUMOUR PROGRESSION AND INVASION (2010) (0)
Screening for hepatitis C at the emergency department: Babyboomers should also be screened in Belgium (2018) (0)
Author and Subject Index (1999) (0)
Patients with hepatocellular carcinoma (HCC) listed for liver transplantation (LTX) outside the MELD system: outcome of a multicenter Eurotransplant series (2005) (0)
Adipose tissue inflammatory gene signatures in NASH 1 Association of Adipose Tissue Inflammation With Histological Severity of Non-alcoholic Fatty Liver Disease (2015) (0)
Hepatic progenitor cells in acute and chronic liver disease: Clinical aspects (2010) (0)
Transplantation of livers recovered after euthanesia: a single centre experience (2017) (0)
Indications, surgical aspects, and results of cluster {liver/pancreas/duodenum/(bowel)} transplantation (2007) (0)
IL 10 associated downstream signalling pathways play a central role in severe monocyte dysfunction during acute-on-chronic liver failure (2016) (0)
970 OCCURRENCE AND CLINICOPATHOLOGICAL RELEVANCE OF PROGNOSTIC MARKERS IN HEPATOCELLULAR CARCINOMA (2011) (0)
P866 EVEROLIMUS-BASED IMMUNOSUPPRESSION PROVIDES SUPERIOR RENAL FUNCTION AND COMPARABLE EFFICACY VERSUS STANDARD TACROLIMUS IN DE NOVO LIVER TRANSPLANTATION: 3-YEAR RESULTS FROM H2304 STUDY EXTENSION (2014) (0)
Safety of Paritaprevir/Ritonavir/Ombitasvir + Dasabuvir with or without rivavirin in HCV Genotype 1-infected Patients : Results from Phase 2 a,d 3 Trails (2015) (0)
Transjugulaire intrahepatische portosystemische shunts (TIPS): nut van gecoverde stents (2005) (0)
Serum gamma-glutamyltransferase is a prognostic biomarker in primary biliary cholangitis and improves risk stratification based on alkaline phosphatase (2020) (0)
EXPRESSION OF BILE SALT AND ATP-BINDING CASSETTE (ABC) TRANSPORTERS IN HUMAN LIVERS WITH FIBROSING CHOLESTATIC HEPATITIS SECONDARY TO RECURRENT HEPATITIS C AFTER LIVER TRANSPLANTATION (2008) (0)
Gene transfer of ceNOS induces long-term control of portal hypertension in CCl4 cirrhotic rats (1998) (0)
Liver transplantation (LTx) without steroids (1999) (0)
More on clinical renal genetics. (2010) (0)
Analysis of the HCV genotype 5a molecular epidemiology in Belgium using a Bayesian approach (2005) (0)
A global risk gene score predicts early and late tumor recurrence after resection of hepatocellular carcinoma (2015) (0)
Personalized subcutaneous administration of hepatitis B surface antibodies without nucleos(t)ide analogues is highly effective and reduces cost for hepatitis B prophylaxis after liver transplantation (2017) (0)
P1177 : Risk factors for hepatic decompensation in primary biliary cirrhosis - results of an international follow up study of 2326 patients (2015) (0)
LIVER TRANSPLANTATION USING CAVO-PORTAL TRANSPOSITION: AN EFFECTIVE TREATMENT IN PATIENTS WITH COMPLETE SPLANCHNIC VENOUS THROMBOSIS (2004) (0)
Two rare cases of acute liver failure after gastric bypass (2018) (0)
Combination therapy of nitrates and spironolactone in the treatment of portal hypertension (1996) (0)
General supportive management (2013) (0)
Everolimus is effective and safe in maintenance liver transplant recipients: results of a multi center, randomized conversion trial. (2008) (0)
Ursodeoxycholic Acid Treatment-Induced GLOBE Score Changes Are Associated With Liver Transplantation-Free Survival in Patients With Primary Biliary Cholangitis. (2023) (0)
No immune graft loss under an AB initio steroid-free immunosuppressive protocol: a two year follow-up (2001) (0)
858 UNIVERSAL HEPATOCYTE DIFFERENTIATION PROTOCOL FOR MULTIPOTENT ADULT PROGENITOR CELLS, EMBRYONIC AND INDUCED PLURIPOTENT STEM CELLS (2009) (0)
Analysis of NGS data from heterogeneous HCV1b populations (2014) (0)
Phylogenetic and statistical analysis of an unexpected HCV genotype 5a cluster in Belgium (2005) (0)
Is Interferon always contraindicated after kidney transplantation (2011) (0)
Carbon monoxide regulates the intrahepatic vascular tone in normal and cirrhotic rats (2007) (0)
Human pluripotent stem cell-derived hepatocytes support complete replication of hepatitis C virus (vol 57, pg 246, 2012) (2013) (0)
Severe colitis in young male adults transplanted for PSC (2004) (0)
LIVER TRANSPLANTATION IN POLYCYSTIC LIVER DISEASE : EXCELLENT SURVIVAL AND IMPROVEMENT OF QUALITY OF LIFE (2009) (0)
Time trends in major hepatic complications in primary biliary cholangitis : incidence and transplant-free survival (2017) (0)
P2-057: The burden of viral hepatitis C in key subgroups in Belgium: targets for micro-elimination (2018) (0)
Letter to the editor: survival in placebo-treated patients with severe alcoholic hepatitis. (2023) (0)
Warren shunt for portal hypertension due to idiopathic portal vein thrombosis: back to shunt-surgery (2005) (0)
EARLY ALLOGRAFT DYSFUNCTION DECREASES PATIENT SURVIVAL AFTER LIVER TRANSPLANTATION (2014) (0)
Hepatitis E virus genotype 3 subtype dependent clinical outcomes in Belgium 2010–2018 (2020) (0)
Genotyping of hepatitis C virus 5a strains using INNO-LiPA HCV II reverse hybridization line probe assay (2004) (0)
Ritanserin decreases portal pressure (PP) in portal vein ligated and cirrhotic rats (1991) (0)
Evolution of the underlying myeproliferative disorder in budd-chiari patients treated with liver transplantation (2015) (0)
Search for an objective parameter of the severity of polycystic liver disease (2012) (0)
Endothelial dysfunction in cirrhotic rat livers may involve both NO and superoxide (2001) (0)
489 ANTIVIRAL TREATMENT IMPROVES SURVIVAL OF PATIENTS WITH CHOLESTATIC FIBROSING HEPATITIS AFTER LIVER TRANSPLANTATION FOR HEPATITIS C (2009) (0)
FRI-021-Comparing the predictive performance of the Mayo risk score and the GLOBE score in a large cohort of patients with primary biliary cholangitis (2019) (0)
THU-387-Eliminating viral hepatitis C in Belgium: A mathematical model of the micro-elimination approach (2019) (0)
The effect of re-exposure to somatostatin analogues in patients with polycystic liver disease (2018) (0)
Chronic hepatitis B therapy with lamivudine in clinical practice - Summary of the discussion - Concluding remarks by the moderators (2000) (0)
Combined liver and double-lung transplantation with > 11 hours of normothermic lung preservation (2014) (0)
Indications and results of combined liver/kidney transplantation: single center experience (2013) (0)
Cessation of nucleos(t)ide analogue treatment after HBeAg seroconversion is associated with a 4-fold increased risk of relapse in cirrhotic compared to non-cirrhotic patients (2017) (0)
Total liver volume measurement by CT corrected for body surface area is an objective parameter of the extent of polycystic liver disease (2011) (0)
Patients with fundal variceal bleeding have frequently large portosystemic shunts which makes them at risk for thrombosis and encephalopathy after tips (1999) (0)
Massive blood transfusion independently compromises outcome after liver transplantation (2014) (0)
Obeticholic Acid in Primary Biliary Cholangitis REPLY (2016) (0)
Association between delayed graft function and patient survival in liver transplantation (2013) (0)
663 THE ROLE OF HISTOLOGY IN THE PROGNOSIS OF LIVER ADENOMATOSIS (2013) (0)
124 HEPATOCYTES DERIVED FROM HUMAN PLURIPOTENT STEM CELLS PERMIT COMPLETE REPLICATION OF THE HEPATITIS C VIRUS (2012) (0)
Histologic stage is a stronger predictor of transplant free survival than APRI and FIB-4 in patients with primary biliary cholangitis (2018) (0)
Cohesins: Novel Markers for the Efficacy of Sorafenib in Hepatocellular Carcinoma (2014) (0)
Ductular reaction and its microenvironment is aetiology driven (2020) (0)
Carbon dioxide insufflation reduces the discomfort due to colonoscopy as obje ctively analyzed by (2013) (0)
Mesenchymal Stem Cell Transplantation in Liver Diseases. (2022) (0)
Interim 12-Month Analysis of the Liver Transplant Study REFINE: Comparison between CNI-Treated Patients Who Received Steroids or Were Steroid-Free (2010) (0)
Embolization of spontaneous portosystemic shunts in cirrhotic patients with refractory hepatic encepalopathy : results of a single center prospective exploratory study (2011) (0)
Outcome after liver transplantation using donation after circulatory death donors: a single-center experience (2013) (0)
The kynurenine pathway in cirrhosis. Relationship with the development of acute decompensation and acute-on-chronic liver failure, clinical course and mortality (2018) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Frederik Nevens?

Frederik Nevens is affiliated with the following schools:

KU Leuven

Frederik Nevens's Academic­Influence.com Rankings

Why Is Frederik Nevens Influential?

Frederik Nevens's Published Works

Published Works

What Schools Are Affiliated With Frederik Nevens?

Frederik Nevens's AcademicInfluence.com Rankings